id	sid	tid	token	lemma	pos
cord-275675-gzd75ks9	1	1	key	key	JJ
cord-275675-gzd75ks9	1	2	:	:	:
cord-275675-gzd75ks9	1	3	cord-275675-gzd75ks9	cord-275675-gzd75ks9	NN
cord-275675-gzd75ks9	1	4	authors	author	NNS
cord-275675-gzd75ks9	1	5	:	:	:
cord-275675-gzd75ks9	2	1	Gee	gee	UH
cord-275675-gzd75ks9	2	2	,	,	,
cord-275675-gzd75ks9	2	3	Siobhan	Siobhan	NNP
cord-275675-gzd75ks9	2	4	;	;	:
cord-275675-gzd75ks9	2	5	Taylor	Taylor	NNP
cord-275675-gzd75ks9	2	6	,	,	,
cord-275675-gzd75ks9	2	7	David	David	NNP
cord-275675-gzd75ks9	2	8	title	title	NN
cord-275675-gzd75ks9	2	9	:	:	:
cord-275675-gzd75ks9	2	10	The	the	DT
cord-275675-gzd75ks9	2	11	effect	effect	NN
cord-275675-gzd75ks9	2	12	of	of	IN
cord-275675-gzd75ks9	2	13	COVID-19	covid-19	NN
cord-275675-gzd75ks9	2	14	on	on	IN
cord-275675-gzd75ks9	2	15	absolute	absolute	JJ
cord-275675-gzd75ks9	2	16	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	2	17	counts	count	NNS
cord-275675-gzd75ks9	2	18	in	in	IN
cord-275675-gzd75ks9	2	19	patients	patient	NNS
cord-275675-gzd75ks9	2	20	taking	take	VBG
cord-275675-gzd75ks9	2	21	clozapine	clozapine	JJ
cord-275675-gzd75ks9	2	22	date	date	NN
cord-275675-gzd75ks9	2	23	:	:	:
cord-275675-gzd75ks9	2	24	2020	2020	CD
cord-275675-gzd75ks9	2	25	-	-	HYPH
cord-275675-gzd75ks9	2	26	07	07	CD
cord-275675-gzd75ks9	2	27	-	-	HYPH
cord-275675-gzd75ks9	2	28	16	16	CD
cord-275675-gzd75ks9	2	29	journal	journal	NN
cord-275675-gzd75ks9	2	30	:	:	:
cord-275675-gzd75ks9	3	1	Ther	Ther	NNP
cord-275675-gzd75ks9	3	2	Adv	Adv	NNP
cord-275675-gzd75ks9	3	3	Psychopharmacol	Psychopharmacol	NNP
cord-275675-gzd75ks9	3	4	DOI	DOI	NNP
cord-275675-gzd75ks9	3	5	:	:	:
cord-275675-gzd75ks9	3	6	10.1177/2045125320940935	10.1177/2045125320940935	CD
cord-275675-gzd75ks9	4	1	sha	sha	NNP
cord-275675-gzd75ks9	4	2	:	:	:
cord-275675-gzd75ks9	5	1	4508ecb0bb0f0755f49b993da85f9a6e09f87891	4508ecb0bb0f0755f49b993da85f9a6e09f87891	CD
cord-275675-gzd75ks9	5	2	doc_id	doc_id	CD
cord-275675-gzd75ks9	5	3	:	:	:
cord-275675-gzd75ks9	6	1	275675	275675	CD
cord-275675-gzd75ks9	6	2	cord_uid	cord_uid	NNS
cord-275675-gzd75ks9	6	3	:	:	:
cord-275675-gzd75ks9	7	1	gzd75ks9	gzd75ks9	JJ
cord-275675-gzd75ks9	7	2	Clozapine	Clozapine	NNP
cord-275675-gzd75ks9	7	3	is	be	VBZ
cord-275675-gzd75ks9	7	4	associated	associate	VBN
cord-275675-gzd75ks9	7	5	with	with	IN
cord-275675-gzd75ks9	7	6	haematological	haematological	JJ
cord-275675-gzd75ks9	7	7	side	side	NN
cord-275675-gzd75ks9	7	8	effects	effect	NNS
cord-275675-gzd75ks9	7	9	,	,	,
cord-275675-gzd75ks9	7	10	including	include	VBG
cord-275675-gzd75ks9	7	11	neutropaenia	neutropaenia	NNP
cord-275675-gzd75ks9	7	12	,	,	,
cord-275675-gzd75ks9	7	13	which	which	WDT
cord-275675-gzd75ks9	7	14	can	can	MD
cord-275675-gzd75ks9	7	15	signal	signal	VB
cord-275675-gzd75ks9	7	16	impending	impending	JJ
cord-275675-gzd75ks9	7	17	life	life	NN
cord-275675-gzd75ks9	7	18	-	-	HYPH
cord-275675-gzd75ks9	7	19	threatening	threaten	VBG
cord-275675-gzd75ks9	7	20	agranulocytosis	agranulocytosis	NN
cord-275675-gzd75ks9	7	21	.	.	.
cord-275675-gzd75ks9	8	1	Patients	patient	NNS
cord-275675-gzd75ks9	8	2	with	with	IN
cord-275675-gzd75ks9	8	3	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	8	4	infection	infection	NN
cord-275675-gzd75ks9	8	5	frequently	frequently	RB
cord-275675-gzd75ks9	8	6	experience	experience	VBP
cord-275675-gzd75ks9	8	7	lymphopaenia	lymphopaenia	NNP
cord-275675-gzd75ks9	8	8	,	,	,
cord-275675-gzd75ks9	8	9	but	but	CC
cord-275675-gzd75ks9	8	10	not	not	RB
cord-275675-gzd75ks9	8	11	neutropaenia	neutropaenia	NNP
cord-275675-gzd75ks9	8	12	.	.	.
cord-275675-gzd75ks9	9	1	We	-PRON-	PRP
cord-275675-gzd75ks9	9	2	present	present	VBP
cord-275675-gzd75ks9	9	3	13	13	CD
cord-275675-gzd75ks9	9	4	patients	patient	NNS
cord-275675-gzd75ks9	9	5	established	establish	VBN
cord-275675-gzd75ks9	9	6	on	on	IN
cord-275675-gzd75ks9	9	7	clozapine	clozapine	NNP
cord-275675-gzd75ks9	9	8	who	who	WP
cord-275675-gzd75ks9	9	9	developed	develop	VBD
cord-275675-gzd75ks9	9	10	COVID-19	covid-19	CD
cord-275675-gzd75ks9	9	11	infection	infection	NN
cord-275675-gzd75ks9	9	12	.	.	.
cord-275675-gzd75ks9	10	1	There	there	EX
cord-275675-gzd75ks9	10	2	were	be	VBD
cord-275675-gzd75ks9	10	3	no	no	DT
cord-275675-gzd75ks9	10	4	significant	significant	JJ
cord-275675-gzd75ks9	10	5	differences	difference	NNS
cord-275675-gzd75ks9	10	6	in	in	IN
cord-275675-gzd75ks9	10	7	total	total	JJ
cord-275675-gzd75ks9	10	8	white	white	JJ
cord-275675-gzd75ks9	10	9	cell	cell	NN
cord-275675-gzd75ks9	10	10	or	or	CC
cord-275675-gzd75ks9	10	11	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	10	12	counts	count	NNS
cord-275675-gzd75ks9	10	13	between	between	IN
cord-275675-gzd75ks9	10	14	pre	pre	JJ
cord-275675-gzd75ks9	10	15	-	-	JJ
cord-275675-gzd75ks9	10	16	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	10	17	,	,	,
cord-275675-gzd75ks9	10	18	intra	intra	NNP
cord-275675-gzd75ks9	10	19	-	-	JJ
cord-275675-gzd75ks9	10	20	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	10	21	or	or	CC
cord-275675-gzd75ks9	10	22	post	post	JJ
cord-275675-gzd75ks9	10	23	-	-	JJ
cord-275675-gzd75ks9	10	24	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	10	25	periods	period	NNS
cord-275675-gzd75ks9	10	26	.	.	.
cord-275675-gzd75ks9	11	1	We	-PRON-	PRP
cord-275675-gzd75ks9	11	2	therefore	therefore	RB
cord-275675-gzd75ks9	11	3	suggest	suggest	VBP
cord-275675-gzd75ks9	11	4	that	that	IN
cord-275675-gzd75ks9	11	5	patients	patient	NNS
cord-275675-gzd75ks9	11	6	who	who	WP
cord-275675-gzd75ks9	11	7	develop	develop	VBP
cord-275675-gzd75ks9	11	8	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	11	9	should	should	MD
cord-275675-gzd75ks9	11	10	generally	generally	RB
cord-275675-gzd75ks9	11	11	have	have	VB
cord-275675-gzd75ks9	11	12	their	-PRON-	PRP$
cord-275675-gzd75ks9	11	13	clozapine	clozapine	NN
cord-275675-gzd75ks9	11	14	treatment	treatment	NN
cord-275675-gzd75ks9	11	15	continued	continue	VBD
cord-275675-gzd75ks9	11	16	.	.	.
cord-275675-gzd75ks9	12	1	Patients	patient	NNS
cord-275675-gzd75ks9	12	2	taking	take	VBG
cord-275675-gzd75ks9	12	3	clozapine	clozapine	NN
cord-275675-gzd75ks9	12	4	who	who	WP
cord-275675-gzd75ks9	12	5	develop	develop	VBP
cord-275675-gzd75ks9	12	6	neutroapaenia	neutroapaenia	NNP
cord-275675-gzd75ks9	12	7	during	during	IN
cord-275675-gzd75ks9	12	8	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	12	9	infection	infection	NN
cord-275675-gzd75ks9	12	10	should	should	MD
cord-275675-gzd75ks9	12	11	be	be	VB
cord-275675-gzd75ks9	12	12	investigated	investigate	VBN
cord-275675-gzd75ks9	12	13	and	and	CC
cord-275675-gzd75ks9	12	14	monitored	monitor	VBN
cord-275675-gzd75ks9	12	15	as	as	IN
cord-275675-gzd75ks9	12	16	in	in	IN
cord-275675-gzd75ks9	12	17	normal	normal	JJ
cord-275675-gzd75ks9	12	18	practice	practice	NN
cord-275675-gzd75ks9	12	19	,	,	,
cord-275675-gzd75ks9	12	20	because	because	IN
cord-275675-gzd75ks9	12	21	changes	change	NNS
cord-275675-gzd75ks9	12	22	in	in	IN
cord-275675-gzd75ks9	12	23	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	12	24	counts	count	NNS
cord-275675-gzd75ks9	12	25	can	can	MD
cord-275675-gzd75ks9	12	26	not	not	RB
cord-275675-gzd75ks9	12	27	be	be	VB
cord-275675-gzd75ks9	12	28	assumed	assume	VBN
cord-275675-gzd75ks9	12	29	to	to	TO
cord-275675-gzd75ks9	12	30	be	be	VB
cord-275675-gzd75ks9	12	31	due	due	JJ
cord-275675-gzd75ks9	12	32	to	to	IN
cord-275675-gzd75ks9	12	33	the	the	DT
cord-275675-gzd75ks9	12	34	viral	viral	JJ
cord-275675-gzd75ks9	12	35	infection	infection	NN
cord-275675-gzd75ks9	12	36	.	.	.
cord-275675-gzd75ks9	13	1	Clozapine	Clozapine	NNP
cord-275675-gzd75ks9	13	2	has	have	VBZ
cord-275675-gzd75ks9	13	3	known	know	VBN
cord-275675-gzd75ks9	13	4	haematological	haematological	JJ
cord-275675-gzd75ks9	13	5	side	side	NN
cord-275675-gzd75ks9	13	6	effects	effect	NNS
cord-275675-gzd75ks9	13	7	.	.	.
cord-275675-gzd75ks9	14	1	The	the	DT
cord-275675-gzd75ks9	14	2	most	most	RBS
cord-275675-gzd75ks9	14	3	common	common	JJ
cord-275675-gzd75ks9	14	4	(	(	-LRB-
cord-275675-gzd75ks9	14	5	2.7	2.7	CD
cord-275675-gzd75ks9	14	6	%	%	NN
cord-275675-gzd75ks9	14	7	of	of	IN
cord-275675-gzd75ks9	14	8	patients	patient	NNS
cord-275675-gzd75ks9	14	9	1	1	CD
cord-275675-gzd75ks9	14	10	)	)	-RRB-
cord-275675-gzd75ks9	14	11	is	be	VBZ
cord-275675-gzd75ks9	14	12	neutropaenia	neutropaenia	NNP
cord-275675-gzd75ks9	14	13	,	,	,
cord-275675-gzd75ks9	14	14	which	which	WDT
cord-275675-gzd75ks9	14	15	can	can	MD
cord-275675-gzd75ks9	14	16	sometimes	sometimes	RB
cord-275675-gzd75ks9	14	17	portend	portend	VB
cord-275675-gzd75ks9	14	18	life	life	NN
cord-275675-gzd75ks9	14	19	-	-	HYPH
cord-275675-gzd75ks9	14	20	threatening	threaten	VBG
cord-275675-gzd75ks9	14	21	agranulocytosis	agranulocytosis	NN
cord-275675-gzd75ks9	14	22	(	(	-LRB-
cord-275675-gzd75ks9	14	23	0.4	0.4	CD
cord-275675-gzd75ks9	14	24	%	%	NN
cord-275675-gzd75ks9	14	25	of	of	IN
cord-275675-gzd75ks9	14	26	patients	patient	NNS
cord-275675-gzd75ks9	14	27	)	)	-RRB-
cord-275675-gzd75ks9	14	28	.	.	.
cord-275675-gzd75ks9	15	1	2	2	LS
cord-275675-gzd75ks9	16	1	For	for	IN
cord-275675-gzd75ks9	16	2	this	this	DT
cord-275675-gzd75ks9	16	3	reason	reason	NN
cord-275675-gzd75ks9	16	4	,	,	,
cord-275675-gzd75ks9	16	5	monitoring	monitoring	NN
cord-275675-gzd75ks9	16	6	of	of	IN
cord-275675-gzd75ks9	16	7	the	the	DT
cord-275675-gzd75ks9	16	8	WCC	WCC	NNP
cord-275675-gzd75ks9	16	9	[	[	-LRB-
cord-275675-gzd75ks9	16	10	including	include	VBG
cord-275675-gzd75ks9	16	11	absolute	absolute	JJ
cord-275675-gzd75ks9	16	12	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	16	13	count	count	NN
cord-275675-gzd75ks9	16	14	(	(	-LRB-
cord-275675-gzd75ks9	16	15	ANC	ANC	NNP
cord-275675-gzd75ks9	16	16	)	)	-RRB-
cord-275675-gzd75ks9	16	17	]	]	-RRB-
cord-275675-gzd75ks9	16	18	is	be	VBZ
cord-275675-gzd75ks9	16	19	mandatory	mandatory	JJ
cord-275675-gzd75ks9	16	20	in	in	IN
cord-275675-gzd75ks9	16	21	many	many	JJ
cord-275675-gzd75ks9	16	22	countries	country	NNS
cord-275675-gzd75ks9	16	23	.	.	.
cord-275675-gzd75ks9	17	1	3	3	CD
cord-275675-gzd75ks9	17	2	Over	over	IN
cord-275675-gzd75ks9	17	3	80	80	CD
cord-275675-gzd75ks9	17	4	%	%	NN
cord-275675-gzd75ks9	17	5	of	of	IN
cord-275675-gzd75ks9	17	6	cases	case	NNS
cord-275675-gzd75ks9	17	7	of	of	IN
cord-275675-gzd75ks9	17	8	agranulocytosis	agranulocytosis	NN
cord-275675-gzd75ks9	17	9	occur	occur	VBP
cord-275675-gzd75ks9	17	10	in	in	IN
cord-275675-gzd75ks9	17	11	the	the	DT
cord-275675-gzd75ks9	17	12	first	first	JJ
cord-275675-gzd75ks9	17	13	18	18	CD
cord-275675-gzd75ks9	17	14	weeks	week	NNS
cord-275675-gzd75ks9	17	15	of	of	IN
cord-275675-gzd75ks9	17	16	treatment	treatment	NN
cord-275675-gzd75ks9	17	17	.	.	.
cord-275675-gzd75ks9	18	1	4	4	LS
cord-275675-gzd75ks9	19	1	By	by	IN
cord-275675-gzd75ks9	19	2	the	the	DT
cord-275675-gzd75ks9	19	3	end	end	NN
cord-275675-gzd75ks9	19	4	of	of	IN
cord-275675-gzd75ks9	19	5	the	the	DT
cord-275675-gzd75ks9	19	6	first	first	JJ
cord-275675-gzd75ks9	19	7	year	year	NN
cord-275675-gzd75ks9	19	8	of	of	IN
cord-275675-gzd75ks9	19	9	treatment	treatment	NN
cord-275675-gzd75ks9	19	10	,	,	,
cord-275675-gzd75ks9	19	11	the	the	DT
cord-275675-gzd75ks9	19	12	risk	risk	NN
cord-275675-gzd75ks9	19	13	of	of	IN
cord-275675-gzd75ks9	19	14	agranulocytosis	agranulocytosis	NN
cord-275675-gzd75ks9	19	15	is	be	VBZ
cord-275675-gzd75ks9	19	16	comparable	comparable	JJ
cord-275675-gzd75ks9	19	17	with	with	IN
cord-275675-gzd75ks9	19	18	that	that	DT
cord-275675-gzd75ks9	19	19	of	of	IN
cord-275675-gzd75ks9	19	20	other	other	JJ
cord-275675-gzd75ks9	19	21	antipsychotics	antipsychotic	NNS
cord-275675-gzd75ks9	19	22	.	.	.
cord-275675-gzd75ks9	20	1	5	5	LS
cord-275675-gzd75ks9	21	1	Neutrophil	Neutrophil	NNP
cord-275675-gzd75ks9	21	2	counts	count	NNS
cord-275675-gzd75ks9	21	3	of	of	IN
cord-275675-gzd75ks9	21	4	0.5	0.5	CD
cord-275675-gzd75ks9	21	5	-	-	SYM
cord-275675-gzd75ks9	21	6	1.5	1.5	CD
cord-275675-gzd75ks9	21	7	×	×	NN
cord-275675-gzd75ks9	21	8	10	10	CD
cord-275675-gzd75ks9	21	9	9	9	CD
cord-275675-gzd75ks9	21	10	/l	/l	.
cord-275675-gzd75ks9	21	11	(	(	-LRB-
cord-275675-gzd75ks9	21	12	mild	mild	JJ
cord-275675-gzd75ks9	21	13	-	-	HYPH
cord-275675-gzd75ks9	21	14	to	to	IN
cord-275675-gzd75ks9	21	15	-	-	HYPH
cord-275675-gzd75ks9	21	16	moderate	moderate	JJ
cord-275675-gzd75ks9	21	17	neutropenia	neutropenia	NNS
cord-275675-gzd75ks9	21	18	)	)	-RRB-
cord-275675-gzd75ks9	21	19	are	be	VBP
cord-275675-gzd75ks9	21	20	not	not	RB
cord-275675-gzd75ks9	21	21	associated	associate	VBN
cord-275675-gzd75ks9	21	22	with	with	IN
cord-275675-gzd75ks9	21	23	a	a	DT
cord-275675-gzd75ks9	21	24	significantly	significantly	RB
cord-275675-gzd75ks9	21	25	increased	increase	VBN
cord-275675-gzd75ks9	21	26	risk	risk	NN
cord-275675-gzd75ks9	21	27	of	of	IN
cord-275675-gzd75ks9	21	28	infection	infection	NN
cord-275675-gzd75ks9	21	29	.	.	.
cord-275675-gzd75ks9	22	1	6	6	CD
cord-275675-gzd75ks9	23	1	Agranulocytosis	agranulocytosis	NN
cord-275675-gzd75ks9	23	2	in	in	IN
cord-275675-gzd75ks9	23	3	this	this	DT
cord-275675-gzd75ks9	23	4	context	context	NN
cord-275675-gzd75ks9	23	5	is	be	VBZ
cord-275675-gzd75ks9	23	6	defined	define	VBN
cord-275675-gzd75ks9	23	7	as	as	IN
cord-275675-gzd75ks9	23	8	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	23	9	counts	count	NNS
cord-275675-gzd75ks9	23	10	of	of	IN
cord-275675-gzd75ks9	23	11	<	<	$
cord-275675-gzd75ks9	23	12	0.5	0.5	CD
cord-275675-gzd75ks9	23	13	×	×	CD
cord-275675-gzd75ks9	23	14	10	10	CD
cord-275675-gzd75ks9	23	15	9	9	CD
cord-275675-gzd75ks9	23	16	/l	/l	NN
cord-275675-gzd75ks9	23	17	,	,	,
cord-275675-gzd75ks9	23	18	where	where	WRB
cord-275675-gzd75ks9	23	19	the	the	DT
cord-275675-gzd75ks9	23	20	case	case	NN
cord-275675-gzd75ks9	23	21	fatality	fatality	NN
cord-275675-gzd75ks9	23	22	rate	rate	NN
cord-275675-gzd75ks9	23	23	is	be	VBZ
cord-275675-gzd75ks9	23	24	between	between	IN
cord-275675-gzd75ks9	23	25	2	2	CD
cord-275675-gzd75ks9	23	26	%	%	NN
cord-275675-gzd75ks9	23	27	and	and	CC
cord-275675-gzd75ks9	23	28	4	4	CD
cord-275675-gzd75ks9	23	29	%	%	NN
cord-275675-gzd75ks9	23	30	.	.	.
cord-275675-gzd75ks9	24	1	7	7	CD
cord-275675-gzd75ks9	24	2	Current	current	JJ
cord-275675-gzd75ks9	24	3	data	datum	NNS
cord-275675-gzd75ks9	24	4	suggest	suggest	VBP
cord-275675-gzd75ks9	24	5	that	that	IN
cord-275675-gzd75ks9	24	6	COVID-19	covid-19	CD
cord-275675-gzd75ks9	24	7	infection	infection	NN
cord-275675-gzd75ks9	24	8	results	result	VBZ
cord-275675-gzd75ks9	24	9	in	in	IN
cord-275675-gzd75ks9	24	10	a	a	DT
cord-275675-gzd75ks9	24	11	lowered	lower	VBN
cord-275675-gzd75ks9	24	12	white	white	JJ
cord-275675-gzd75ks9	24	13	cell	cell	NN
cord-275675-gzd75ks9	24	14	count	count	NN
cord-275675-gzd75ks9	24	15	(	(	-LRB-
cord-275675-gzd75ks9	24	16	WCC	WCC	NNP
cord-275675-gzd75ks9	24	17	)	)	-RRB-
cord-275675-gzd75ks9	24	18	of	of	IN
cord-275675-gzd75ks9	24	19	<	<	NNP
cord-275675-gzd75ks9	24	20	4.0	4.0	CD
cord-275675-gzd75ks9	24	21	×	×	NN
cord-275675-gzd75ks9	24	22	10	10	CD
cord-275675-gzd75ks9	24	23	9	9	CD
cord-275675-gzd75ks9	24	24	/l	/l	NN
cord-275675-gzd75ks9	24	25	for	for	IN
cord-275675-gzd75ks9	24	26	between	between	IN
cord-275675-gzd75ks9	24	27	9	9	CD
cord-275675-gzd75ks9	24	28	and	and	CC
cord-275675-gzd75ks9	24	29	45	45	CD
cord-275675-gzd75ks9	24	30	%	%	NN
cord-275675-gzd75ks9	24	31	of	of	IN
cord-275675-gzd75ks9	24	32	patients	patient	NNS
cord-275675-gzd75ks9	24	33	.	.	.
cord-275675-gzd75ks9	25	1	[	[	-LRB-
cord-275675-gzd75ks9	25	2	8	8	CD
cord-275675-gzd75ks9	25	3	]	]	-RRB-
cord-275675-gzd75ks9	25	4	[	[	-LRB-
cord-275675-gzd75ks9	25	5	9	9	CD
cord-275675-gzd75ks9	25	6	]	]	-RRB-
cord-275675-gzd75ks9	25	7	[	[	-LRB-
cord-275675-gzd75ks9	25	8	10	10	CD
cord-275675-gzd75ks9	25	9	]	]	-RRB-
cord-275675-gzd75ks9	25	10	[	[	-LRB-
cord-275675-gzd75ks9	25	11	11	11	CD
cord-275675-gzd75ks9	25	12	]	]	-RRB-
cord-275675-gzd75ks9	25	13	[	[	-LRB-
cord-275675-gzd75ks9	25	14	12	12	CD
cord-275675-gzd75ks9	25	15	]	]	-RRB-
cord-275675-gzd75ks9	26	1	Lymphocytopenia	Lymphocytopenia	NNP
cord-275675-gzd75ks9	26	2	(	(	-LRB-
cord-275675-gzd75ks9	26	3	lymphocytes	lymphocyte	VBZ
cord-275675-gzd75ks9	26	4	<	<	XX
cord-275675-gzd75ks9	26	5	1.5	1.5	CD
cord-275675-gzd75ks9	26	6	×	×	NN
cord-275675-gzd75ks9	26	7	10	10	CD
cord-275675-gzd75ks9	26	8	9	9	CD
cord-275675-gzd75ks9	26	9	/l	/l	NN
cord-275675-gzd75ks9	26	10	)	)	-RRB-
cord-275675-gzd75ks9	26	11	is	be	VBZ
cord-275675-gzd75ks9	26	12	especially	especially	RB
cord-275675-gzd75ks9	26	13	common	common	JJ
cord-275675-gzd75ks9	26	14	,	,	,
cord-275675-gzd75ks9	26	15	being	be	VBG
cord-275675-gzd75ks9	26	16	reported	report	VBN
cord-275675-gzd75ks9	26	17	in	in	IN
cord-275675-gzd75ks9	26	18	33	33	CD
cord-275675-gzd75ks9	26	19	-	-	SYM
cord-275675-gzd75ks9	26	20	83	83	CD
cord-275675-gzd75ks9	26	21	%	%	NN
cord-275675-gzd75ks9	26	22	of	of	IN
cord-275675-gzd75ks9	26	23	patients	patient	NNS
cord-275675-gzd75ks9	26	24	.	.	.
cord-275675-gzd75ks9	27	1	[	[	-LRB-
cord-275675-gzd75ks9	27	2	8	8	CD
cord-275675-gzd75ks9	27	3	]	]	-RRB-
cord-275675-gzd75ks9	27	4	[	[	-LRB-
cord-275675-gzd75ks9	27	5	9	9	CD
cord-275675-gzd75ks9	27	6	]	]	-RRB-
cord-275675-gzd75ks9	27	7	[	[	-LRB-
cord-275675-gzd75ks9	27	8	10	10	CD
cord-275675-gzd75ks9	27	9	]	]	-RRB-
cord-275675-gzd75ks9	27	10	[	[	-LRB-
cord-275675-gzd75ks9	27	11	11	11	CD
cord-275675-gzd75ks9	27	12	]	]	-RRB-
cord-275675-gzd75ks9	28	1	[	[	-LRB-
cord-275675-gzd75ks9	28	2	12	12	CD
cord-275675-gzd75ks9	28	3	]	]	-RRB-
cord-275675-gzd75ks9	28	4	[	[	-LRB-
cord-275675-gzd75ks9	28	5	13	13	CD
cord-275675-gzd75ks9	28	6	]	]	-RRB-
cord-275675-gzd75ks9	28	7	More	more	RBR
cord-275675-gzd75ks9	28	8	severe	severe	JJ
cord-275675-gzd75ks9	28	9	abnormalities	abnormality	NNS
cord-275675-gzd75ks9	28	10	correlate	correlate	VBP
cord-275675-gzd75ks9	28	11	with	with	IN
cord-275675-gzd75ks9	28	12	severity	severity	NN
cord-275675-gzd75ks9	28	13	of	of	IN
cord-275675-gzd75ks9	28	14	the	the	DT
cord-275675-gzd75ks9	28	15	disease	disease	NN
cord-275675-gzd75ks9	28	16	;	;	:
cord-275675-gzd75ks9	28	17	lower	low	JJR
cord-275675-gzd75ks9	28	18	counts	count	NNS
cord-275675-gzd75ks9	28	19	are	be	VBP
cord-275675-gzd75ks9	28	20	seen	see	VBN
cord-275675-gzd75ks9	28	21	in	in	IN
cord-275675-gzd75ks9	28	22	those	those	DT
cord-275675-gzd75ks9	28	23	for	for	IN
cord-275675-gzd75ks9	28	24	whom	whom	WP
cord-275675-gzd75ks9	28	25	infection	infection	NN
cord-275675-gzd75ks9	28	26	is	be	VBZ
cord-275675-gzd75ks9	28	27	fatal	fatal	JJ
cord-275675-gzd75ks9	28	28	.	.	.
cord-275675-gzd75ks9	29	1	In	in	IN
cord-275675-gzd75ks9	29	2	contrast	contrast	NN
cord-275675-gzd75ks9	29	3	,	,	,
cord-275675-gzd75ks9	29	4	studies	study	NNS
cord-275675-gzd75ks9	29	5	in	in	IN
cord-275675-gzd75ks9	29	6	COVID-19	covid-19	CD
cord-275675-gzd75ks9	29	7	patients	patient	NNS
cord-275675-gzd75ks9	29	8	have	have	VBP
cord-275675-gzd75ks9	29	9	found	find	VBN
cord-275675-gzd75ks9	29	10	neutrophils	neutrophil	NNS
cord-275675-gzd75ks9	29	11	to	to	TO
cord-275675-gzd75ks9	29	12	be	be	VB
cord-275675-gzd75ks9	29	13	in	in	IN
cord-275675-gzd75ks9	29	14	the	the	DT
cord-275675-gzd75ks9	29	15	normal	normal	JJ
cord-275675-gzd75ks9	29	16	range	range	NN
cord-275675-gzd75ks9	29	17	(	(	-LRB-
cord-275675-gzd75ks9	29	18	3.0	3.0	CD
cord-275675-gzd75ks9	29	19	-	-	SYM
cord-275675-gzd75ks9	29	20	7.5	7.5	CD
cord-275675-gzd75ks9	29	21	×	×	NN
cord-275675-gzd75ks9	29	22	10	10	CD
cord-275675-gzd75ks9	29	23	9	9	CD
cord-275675-gzd75ks9	29	24	/l	/l	NN
cord-275675-gzd75ks9	29	25	)	)	-RRB-
cord-275675-gzd75ks9	29	26	.	.	.
cord-275675-gzd75ks9	30	1	8	8	CD
cord-275675-gzd75ks9	30	2	,	,	,
cord-275675-gzd75ks9	30	3	9	9	CD
cord-275675-gzd75ks9	30	4	,	,	,
cord-275675-gzd75ks9	30	5	13	13	CD
cord-275675-gzd75ks9	31	1	There	there	EX
cord-275675-gzd75ks9	31	2	are	be	VBP
cord-275675-gzd75ks9	31	3	no	no	DT
cord-275675-gzd75ks9	31	4	published	publish	VBN
cord-275675-gzd75ks9	31	5	data	datum	NNS
cord-275675-gzd75ks9	31	6	describing	describe	VBG
cord-275675-gzd75ks9	31	7	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	31	8	counts	count	NNS
cord-275675-gzd75ks9	31	9	in	in	IN
cord-275675-gzd75ks9	31	10	COVID-19positive	COVID-19positive	NNP
cord-275675-gzd75ks9	31	11	patients	patient	NNS
cord-275675-gzd75ks9	31	12	taking	take	VBG
cord-275675-gzd75ks9	31	13	clozapine	clozapine	NN
cord-275675-gzd75ks9	31	14	.	.	.
cord-275675-gzd75ks9	32	1	We	-PRON-	PRP
cord-275675-gzd75ks9	32	2	present	present	VBP
cord-275675-gzd75ks9	32	3	a	a	DT
cord-275675-gzd75ks9	32	4	series	series	NN
cord-275675-gzd75ks9	32	5	of	of	IN
cord-275675-gzd75ks9	32	6	patients	patient	NNS
cord-275675-gzd75ks9	32	7	who	who	WP
cord-275675-gzd75ks9	32	8	contracted	contract	VBD
cord-275675-gzd75ks9	32	9	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	32	10	whilst	whilst	IN
cord-275675-gzd75ks9	32	11	taking	take	VBG
cord-275675-gzd75ks9	32	12	clozapine	clozapine	NN
cord-275675-gzd75ks9	32	13	.	.	.
cord-275675-gzd75ks9	33	1	Neutrophil	Neutrophil	NNP
cord-275675-gzd75ks9	33	2	counts	count	NNS
cord-275675-gzd75ks9	33	3	and	and	CC
cord-275675-gzd75ks9	33	4	WCCs	wcc	NNS
cord-275675-gzd75ks9	33	5	are	be	VBP
cord-275675-gzd75ks9	33	6	illustrated	illustrate	VBN
cord-275675-gzd75ks9	33	7	for	for	IN
cord-275675-gzd75ks9	33	8	the	the	DT
cord-275675-gzd75ks9	33	9	period	period	NN
cord-275675-gzd75ks9	33	10	prior	prior	RB
cord-275675-gzd75ks9	33	11	to	to	IN
cord-275675-gzd75ks9	33	12	contracting	contracting	NN
cord-275675-gzd75ks9	33	13	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	33	14	,	,	,
cord-275675-gzd75ks9	33	15	during	during	IN
cord-275675-gzd75ks9	33	16	the	the	DT
cord-275675-gzd75ks9	33	17	infection	infection	NN
cord-275675-gzd75ks9	33	18	,	,	,
cord-275675-gzd75ks9	33	19	and	and	CC
cord-275675-gzd75ks9	33	20	after	after	IN
cord-275675-gzd75ks9	33	21	recovery	recovery	NN
cord-275675-gzd75ks9	33	22	.	.	.
cord-275675-gzd75ks9	34	1	All	all	DT
cord-275675-gzd75ks9	34	2	patients	patient	NNS
cord-275675-gzd75ks9	34	3	were	be	VBD
cord-275675-gzd75ks9	34	4	either	either	CC
cord-275675-gzd75ks9	34	5	inpatients	inpatient	NNS
cord-275675-gzd75ks9	34	6	at	at	IN
cord-275675-gzd75ks9	34	7	South	South	NNP
cord-275675-gzd75ks9	34	8	London	London	NNP
cord-275675-gzd75ks9	34	9	and	and	CC
cord-275675-gzd75ks9	34	10	the	the	DT
cord-275675-gzd75ks9	34	11	Maudsley	Maudsley	NNP
cord-275675-gzd75ks9	34	12	NHS	NHS	NNP
cord-275675-gzd75ks9	34	13	Foundation	Foundation	NNP
cord-275675-gzd75ks9	34	14	Trust	Trust	NNP
cord-275675-gzd75ks9	34	15	at	at	IN
cord-275675-gzd75ks9	34	16	the	the	DT
cord-275675-gzd75ks9	34	17	time	time	NN
cord-275675-gzd75ks9	34	18	of	of	IN
cord-275675-gzd75ks9	34	19	testing	testing	NN
cord-275675-gzd75ks9	34	20	positive	positive	JJ
cord-275675-gzd75ks9	34	21	for	for	IN
cord-275675-gzd75ks9	34	22	COVID-19	covid-19	CD
cord-275675-gzd75ks9	34	23	or	or	CC
cord-275675-gzd75ks9	34	24	admitted	admit	VBN
cord-275675-gzd75ks9	34	25	to	to	IN
cord-275675-gzd75ks9	34	26	the	the	DT
cord-275675-gzd75ks9	34	27	neighbouring	neighbouring	JJ
cord-275675-gzd75ks9	34	28	acute	acute	JJ
cord-275675-gzd75ks9	34	29	trust	trust	NN
cord-275675-gzd75ks9	34	30	and	and	CC
cord-275675-gzd75ks9	34	31	were	be	VBD
cord-275675-gzd75ks9	34	32	under	under	IN
cord-275675-gzd75ks9	34	33	the	the	DT
cord-275675-gzd75ks9	34	34	care	care	NN
cord-275675-gzd75ks9	34	35	of	of	IN
cord-275675-gzd75ks9	34	36	the	the	DT
cord-275675-gzd75ks9	34	37	psychiatric	psychiatric	JJ
cord-275675-gzd75ks9	34	38	liaison	liaison	NN
cord-275675-gzd75ks9	34	39	team	team	NN
cord-275675-gzd75ks9	34	40	.	.	.
cord-275675-gzd75ks9	35	1	The	the	DT
cord-275675-gzd75ks9	35	2	ANC	ANC	NNP
cord-275675-gzd75ks9	35	3	taken	take	VBD
cord-275675-gzd75ks9	35	4	a	a	DT
cord-275675-gzd75ks9	35	5	minimum	minimum	NN
cord-275675-gzd75ks9	35	6	of	of	IN
cord-275675-gzd75ks9	35	7	14	14	CD
cord-275675-gzd75ks9	35	8	days	day	NNS
cord-275675-gzd75ks9	35	9	prior	prior	RB
cord-275675-gzd75ks9	35	10	to	to	IN
cord-275675-gzd75ks9	35	11	a	a	DT
cord-275675-gzd75ks9	35	12	positive	positive	JJ
cord-275675-gzd75ks9	35	13	nasopharyngeal	nasopharyngeal	JJ
cord-275675-gzd75ks9	35	14	swab	swab	NN
cord-275675-gzd75ks9	35	15	for	for	IN
cord-275675-gzd75ks9	35	16	viral	viral	JJ
cord-275675-gzd75ks9	35	17	ribonucleic	ribonucleic	NN
cord-275675-gzd75ks9	35	18	acid	acid	NN
cord-275675-gzd75ks9	35	19	of	of	IN
cord-275675-gzd75ks9	35	20	SARS	SARS	NNP
cord-275675-gzd75ks9	35	21	-	-	HYPH
cord-275675-gzd75ks9	35	22	CoV-2	CoV-2	NNP
cord-275675-gzd75ks9	35	23	was	be	VBD
cord-275675-gzd75ks9	35	24	used	use	VBN
cord-275675-gzd75ks9	35	25	as	as	IN
cord-275675-gzd75ks9	35	26	a	a	DT
cord-275675-gzd75ks9	35	27	'	'	``
cord-275675-gzd75ks9	35	28	baseline	baseline	NN
cord-275675-gzd75ks9	35	29	'	'	''
cord-275675-gzd75ks9	35	30	ANC	ANC	NNP
cord-275675-gzd75ks9	35	31	level	level	NN
cord-275675-gzd75ks9	35	32	.	.	.
cord-275675-gzd75ks9	36	1	The	the	DT
cord-275675-gzd75ks9	36	2	day	day	NN
cord-275675-gzd75ks9	36	3	of	of	IN
cord-275675-gzd75ks9	36	4	the	the	DT
cord-275675-gzd75ks9	36	5	positive	positive	JJ
cord-275675-gzd75ks9	36	6	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	36	7	swab	swab	NN
cord-275675-gzd75ks9	36	8	was	be	VBD
cord-275675-gzd75ks9	36	9	designated	designate	VBN
cord-275675-gzd75ks9	36	10	as	as	IN
cord-275675-gzd75ks9	36	11	day	day	NN
cord-275675-gzd75ks9	36	12	0	0	CD
cord-275675-gzd75ks9	36	13	.	.	.
cord-275675-gzd75ks9	37	1	The	the	DT
cord-275675-gzd75ks9	37	2	Clozapine	Clozapine	NNP
cord-275675-gzd75ks9	37	3	is	be	VBZ
cord-275675-gzd75ks9	37	4	associated	associate	VBN
cord-275675-gzd75ks9	37	5	with	with	IN
cord-275675-gzd75ks9	37	6	haematological	haematological	JJ
cord-275675-gzd75ks9	37	7	side	side	NN
cord-275675-gzd75ks9	37	8	effects	effect	NNS
cord-275675-gzd75ks9	37	9	,	,	,
cord-275675-gzd75ks9	37	10	including	include	VBG
cord-275675-gzd75ks9	37	11	neutropaenia	neutropaenia	NNP
cord-275675-gzd75ks9	37	12	,	,	,
cord-275675-gzd75ks9	37	13	which	which	WDT
cord-275675-gzd75ks9	37	14	can	can	MD
cord-275675-gzd75ks9	37	15	signal	signal	VB
cord-275675-gzd75ks9	37	16	impending	impending	JJ
cord-275675-gzd75ks9	37	17	life	life	NN
cord-275675-gzd75ks9	37	18	-	-	HYPH
cord-275675-gzd75ks9	37	19	threatening	threaten	VBG
cord-275675-gzd75ks9	37	20	agranulocytosis	agranulocytosis	NN
cord-275675-gzd75ks9	37	21	.	.	.
cord-275675-gzd75ks9	38	1	Patients	patient	NNS
cord-275675-gzd75ks9	38	2	with	with	IN
cord-275675-gzd75ks9	38	3	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	38	4	infection	infection	NN
cord-275675-gzd75ks9	38	5	frequently	frequently	RB
cord-275675-gzd75ks9	38	6	experience	experience	VBP
cord-275675-gzd75ks9	38	7	lymphopaenia	lymphopaenia	NNP
cord-275675-gzd75ks9	38	8	,	,	,
cord-275675-gzd75ks9	38	9	but	but	CC
cord-275675-gzd75ks9	38	10	not	not	RB
cord-275675-gzd75ks9	38	11	neutropaenia	neutropaenia	NNP
cord-275675-gzd75ks9	38	12	.	.	.
cord-275675-gzd75ks9	39	1	We	-PRON-	PRP
cord-275675-gzd75ks9	39	2	present	present	VBP
cord-275675-gzd75ks9	39	3	13	13	CD
cord-275675-gzd75ks9	39	4	patients	patient	NNS
cord-275675-gzd75ks9	39	5	established	establish	VBN
cord-275675-gzd75ks9	39	6	on	on	IN
cord-275675-gzd75ks9	39	7	clozapine	clozapine	NNP
cord-275675-gzd75ks9	39	8	who	who	WP
cord-275675-gzd75ks9	39	9	developed	develop	VBD
cord-275675-gzd75ks9	39	10	COVID-19	covid-19	CD
cord-275675-gzd75ks9	39	11	infection	infection	NN
cord-275675-gzd75ks9	39	12	.	.	.
cord-275675-gzd75ks9	40	1	There	there	EX
cord-275675-gzd75ks9	40	2	were	be	VBD
cord-275675-gzd75ks9	40	3	no	no	DT
cord-275675-gzd75ks9	40	4	significant	significant	JJ
cord-275675-gzd75ks9	40	5	differences	difference	NNS
cord-275675-gzd75ks9	40	6	in	in	IN
cord-275675-gzd75ks9	40	7	total	total	JJ
cord-275675-gzd75ks9	40	8	white	white	JJ
cord-275675-gzd75ks9	40	9	cell	cell	NN
cord-275675-gzd75ks9	40	10	or	or	CC
cord-275675-gzd75ks9	40	11	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	40	12	counts	count	NNS
cord-275675-gzd75ks9	40	13	between	between	IN
cord-275675-gzd75ks9	40	14	pre	pre	JJ
cord-275675-gzd75ks9	40	15	-	-	JJ
cord-275675-gzd75ks9	40	16	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	40	17	,	,	,
cord-275675-gzd75ks9	40	18	intra	intra	NNP
cord-275675-gzd75ks9	40	19	-	-	JJ
cord-275675-gzd75ks9	40	20	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	40	21	or	or	CC
cord-275675-gzd75ks9	40	22	post	post	JJ
cord-275675-gzd75ks9	40	23	-	-	JJ
cord-275675-gzd75ks9	40	24	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	40	25	periods	period	NNS
cord-275675-gzd75ks9	40	26	.	.	.
cord-275675-gzd75ks9	41	1	We	-PRON-	PRP
cord-275675-gzd75ks9	41	2	therefore	therefore	RB
cord-275675-gzd75ks9	41	3	suggest	suggest	VBP
cord-275675-gzd75ks9	41	4	that	that	IN
cord-275675-gzd75ks9	41	5	patients	patient	NNS
cord-275675-gzd75ks9	41	6	who	who	WP
cord-275675-gzd75ks9	41	7	develop	develop	VBP
cord-275675-gzd75ks9	41	8	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	41	9	should	should	MD
cord-275675-gzd75ks9	41	10	generally	generally	RB
cord-275675-gzd75ks9	41	11	have	have	VB
cord-275675-gzd75ks9	41	12	their	-PRON-	PRP$
cord-275675-gzd75ks9	41	13	clozapine	clozapine	NN
cord-275675-gzd75ks9	41	14	treatment	treatment	NN
cord-275675-gzd75ks9	41	15	continued	continue	VBD
cord-275675-gzd75ks9	41	16	.	.	.
cord-275675-gzd75ks9	42	1	Patients	patient	NNS
cord-275675-gzd75ks9	42	2	taking	take	VBG
cord-275675-gzd75ks9	42	3	clozapine	clozapine	NN
cord-275675-gzd75ks9	42	4	who	who	WP
cord-275675-gzd75ks9	42	5	develop	develop	VBP
cord-275675-gzd75ks9	42	6	neutroapaenia	neutroapaenia	NNP
cord-275675-gzd75ks9	42	7	during	during	IN
cord-275675-gzd75ks9	42	8	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	42	9	infection	infection	NN
cord-275675-gzd75ks9	42	10	should	should	MD
cord-275675-gzd75ks9	42	11	be	be	VB
cord-275675-gzd75ks9	42	12	investigated	investigate	VBN
cord-275675-gzd75ks9	42	13	and	and	CC
cord-275675-gzd75ks9	42	14	monitored	monitor	VBN
cord-275675-gzd75ks9	42	15	as	as	IN
cord-275675-gzd75ks9	42	16	in	in	IN
cord-275675-gzd75ks9	42	17	normal	normal	JJ
cord-275675-gzd75ks9	42	18	practice	practice	NN
cord-275675-gzd75ks9	42	19	,	,	,
cord-275675-gzd75ks9	42	20	because	because	IN
cord-275675-gzd75ks9	42	21	changes	change	NNS
cord-275675-gzd75ks9	42	22	in	in	IN
cord-275675-gzd75ks9	42	23	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	42	24	counts	count	NNS
cord-275675-gzd75ks9	42	25	can	can	MD
cord-275675-gzd75ks9	42	26	not	not	RB
cord-275675-gzd75ks9	42	27	be	be	VB
cord-275675-gzd75ks9	42	28	assumed	assume	VBN
cord-275675-gzd75ks9	42	29	to	to	TO
cord-275675-gzd75ks9	42	30	be	be	VB
cord-275675-gzd75ks9	42	31	due	due	JJ
cord-275675-gzd75ks9	42	32	to	to	IN
cord-275675-gzd75ks9	42	33	the	the	DT
cord-275675-gzd75ks9	42	34	viral	viral	JJ
cord-275675-gzd75ks9	42	35	infection	infection	NN
cord-275675-gzd75ks9	42	36	.	.	.
cord-275675-gzd75ks9	42	37	 	 	_SP
cord-275675-gzd75ks9	43	1	Data	datum	NNS
cord-275675-gzd75ks9	43	2	for	for	IN
cord-275675-gzd75ks9	43	3	13	13	CD
cord-275675-gzd75ks9	43	4	consecutive	consecutive	JJ
cord-275675-gzd75ks9	43	5	patients	patient	NNS
cord-275675-gzd75ks9	43	6	(	(	-LRB-
cord-275675-gzd75ks9	43	7	9	9	CD
cord-275675-gzd75ks9	43	8	female	female	NN
cord-275675-gzd75ks9	43	9	,	,	,
cord-275675-gzd75ks9	43	10	4	4	CD
cord-275675-gzd75ks9	43	11	male	male	NN
cord-275675-gzd75ks9	43	12	)	)	-RRB-
cord-275675-gzd75ks9	43	13	are	be	VBP
cord-275675-gzd75ks9	43	14	presented	present	VBN
cord-275675-gzd75ks9	43	15	(	(	-LRB-
cord-275675-gzd75ks9	43	16	Table	table	NN
cord-275675-gzd75ks9	43	17	1	1	CD
cord-275675-gzd75ks9	43	18	)	)	-RRB-
cord-275675-gzd75ks9	43	19	.	.	.
cord-275675-gzd75ks9	44	1	The	the	DT
cord-275675-gzd75ks9	44	2	mean	mean	JJ
cord-275675-gzd75ks9	44	3	age	age	NN
cord-275675-gzd75ks9	44	4	was	be	VBD
cord-275675-gzd75ks9	44	5	48	48	CD
cord-275675-gzd75ks9	44	6	years	year	NNS
cord-275675-gzd75ks9	44	7	at	at	IN
cord-275675-gzd75ks9	44	8	the	the	DT
cord-275675-gzd75ks9	44	9	time	time	NN
cord-275675-gzd75ks9	44	10	of	of	IN
cord-275675-gzd75ks9	44	11	the	the	DT
cord-275675-gzd75ks9	44	12	positive	positive	JJ
cord-275675-gzd75ks9	44	13	swab	swab	NN
cord-275675-gzd75ks9	44	14	,	,	,
cord-275675-gzd75ks9	44	15	and	and	CC
cord-275675-gzd75ks9	44	16	nine	nine	CD
cord-275675-gzd75ks9	44	17	patients	patient	NNS
cord-275675-gzd75ks9	44	18	were	be	VBD
cord-275675-gzd75ks9	44	19	of	of	IN
cord-275675-gzd75ks9	44	20	non	non	JJ
cord-275675-gzd75ks9	44	21	-	-	JJ
cord-275675-gzd75ks9	44	22	White	white	JJ
cord-275675-gzd75ks9	44	23	background	background	NN
cord-275675-gzd75ks9	44	24	.	.	.
cord-275675-gzd75ks9	45	1	All	all	DT
cord-275675-gzd75ks9	45	2	except	except	IN
cord-275675-gzd75ks9	45	3	two	two	CD
cord-275675-gzd75ks9	45	4	patients	patient	NNS
cord-275675-gzd75ks9	45	5	had	have	VBD
cord-275675-gzd75ks9	45	6	their	-PRON-	PRP$
cord-275675-gzd75ks9	45	7	regular	regular	JJ
cord-275675-gzd75ks9	45	8	clozapine	clozapine	NN
cord-275675-gzd75ks9	45	9	full	full	JJ
cord-275675-gzd75ks9	45	10	blood	blood	NN
cord-275675-gzd75ks9	45	11	count	count	NN
cord-275675-gzd75ks9	45	12	taken	take	VBN
cord-275675-gzd75ks9	45	13	monthly	monthly	RB
cord-275675-gzd75ks9	45	14	and	and	CC
cord-275675-gzd75ks9	45	15	had	have	VBD
cord-275675-gzd75ks9	45	16	therefore	therefore	RB
cord-275675-gzd75ks9	45	17	been	be	VBN
cord-275675-gzd75ks9	45	18	taking	take	VBG
cord-275675-gzd75ks9	45	19	clozapine	clozapine	NN
cord-275675-gzd75ks9	45	20	for	for	IN
cord-275675-gzd75ks9	45	21	more	more	JJR
cord-275675-gzd75ks9	45	22	than	than	IN
cord-275675-gzd75ks9	45	23	a	a	DT
cord-275675-gzd75ks9	45	24	year	year	NN
cord-275675-gzd75ks9	45	25	.	.	.
cord-275675-gzd75ks9	46	1	Two	two	CD
cord-275675-gzd75ks9	46	2	had	have	VBD
cord-275675-gzd75ks9	46	3	a	a	DT
cord-275675-gzd75ks9	46	4	prior	prior	JJ
cord-275675-gzd75ks9	46	5	diagnosis	diagnosis	NN
cord-275675-gzd75ks9	46	6	of	of	IN
cord-275675-gzd75ks9	46	7	benign	benign	JJ
cord-275675-gzd75ks9	46	8	ethnic	ethnic	JJ
cord-275675-gzd75ks9	46	9	neutropaenia	neutropaenia	NNS
cord-275675-gzd75ks9	46	10	(	(	-LRB-
cord-275675-gzd75ks9	46	11	BEN	BEN	NNP
cord-275675-gzd75ks9	46	12	)	)	-RRB-
cord-275675-gzd75ks9	46	13	.	.	.
cord-275675-gzd75ks9	47	1	The	the	DT
cord-275675-gzd75ks9	47	2	mean	mean	JJ
cord-275675-gzd75ks9	47	3	ANC	ANC	NNP
cord-275675-gzd75ks9	47	4	at	at	IN
cord-275675-gzd75ks9	47	5	baseline	baseline	NN
cord-275675-gzd75ks9	47	6	was	be	VBD
cord-275675-gzd75ks9	47	7	4.83	4.83	CD
cord-275675-gzd75ks9	47	8	×	×	NN
cord-275675-gzd75ks9	47	9	10	10	CD
cord-275675-gzd75ks9	47	10	9	9	CD
cord-275675-gzd75ks9	47	11	,	,	,
cord-275675-gzd75ks9	47	12	reducing	reduce	VBG
cord-275675-gzd75ks9	47	13	to	to	IN
cord-275675-gzd75ks9	47	14	4.24	4.24	CD
cord-275675-gzd75ks9	47	15	×	×	NN
cord-275675-gzd75ks9	47	16	10	10	CD
cord-275675-gzd75ks9	47	17	9	9	CD
cord-275675-gzd75ks9	47	18	in	in	IN
cord-275675-gzd75ks9	47	19	the	the	DT
cord-275675-gzd75ks9	47	20	first	first	JJ
cord-275675-gzd75ks9	47	21	week	week	NN
cord-275675-gzd75ks9	47	22	following	follow	VBG
cord-275675-gzd75ks9	47	23	a	a	DT
cord-275675-gzd75ks9	47	24	positive	positive	JJ
cord-275675-gzd75ks9	47	25	COVID-19	covid-19	NN
cord-275675-gzd75ks9	47	26	swab	swab	NN
cord-275675-gzd75ks9	47	27	(	(	-LRB-
cord-275675-gzd75ks9	47	28	Table	Table	NNP
cord-275675-gzd75ks9	47	29	2	2	CD
cord-275675-gzd75ks9	47	30	)	)	-RRB-
cord-275675-gzd75ks9	47	31	.	.	.
cord-275675-gzd75ks9	48	1	Mean	mean	VB
cord-275675-gzd75ks9	48	2	ANC	ANC	NNP
cord-275675-gzd75ks9	48	3	for	for	IN
cord-275675-gzd75ks9	48	4	the	the	DT
cord-275675-gzd75ks9	48	5	second	second	JJ
cord-275675-gzd75ks9	48	6	week	week	NN
cord-275675-gzd75ks9	48	7	was	be	VBD
cord-275675-gzd75ks9	48	8	5.70	5.70	CD
cord-275675-gzd75ks9	48	9	×	×	NN
cord-275675-gzd75ks9	48	10	10	10	CD
cord-275675-gzd75ks9	48	11	9	9	CD
cord-275675-gzd75ks9	48	12	.	.	.
cord-275675-gzd75ks9	49	1	No	no	DT
cord-275675-gzd75ks9	49	2	ANC	ANC	NNP
cord-275675-gzd75ks9	49	3	was	be	VBD
cord-275675-gzd75ks9	49	4	taken	take	VBN
cord-275675-gzd75ks9	49	5	in	in	IN
cord-275675-gzd75ks9	49	6	the	the	DT
cord-275675-gzd75ks9	49	7	time	time	NN
cord-275675-gzd75ks9	49	8	period	period	NN
cord-275675-gzd75ks9	49	9	between	between	IN
cord-275675-gzd75ks9	49	10	days	day	NNS
cord-275675-gzd75ks9	49	11	8	8	CD
cord-275675-gzd75ks9	49	12	and	and	CC
cord-275675-gzd75ks9	49	13	14	14	CD
cord-275675-gzd75ks9	49	14	for	for	IN
cord-275675-gzd75ks9	49	15	one	one	CD
cord-275675-gzd75ks9	49	16	patient	patient	NN
cord-275675-gzd75ks9	49	17	;	;	:
cord-275675-gzd75ks9	49	18	the	the	DT
cord-275675-gzd75ks9	49	19	next	next	JJ
cord-275675-gzd75ks9	49	20	available	available	JJ
cord-275675-gzd75ks9	49	21	ANC	ANC	NNP
cord-275675-gzd75ks9	49	22	was	be	VBD
cord-275675-gzd75ks9	49	23	used	use	VBN
cord-275675-gzd75ks9	49	24	as	as	IN
cord-275675-gzd75ks9	49	25	representative	representative	NN
cord-275675-gzd75ks9	49	26	of	of	IN
cord-275675-gzd75ks9	49	27	the	the	DT
cord-275675-gzd75ks9	49	28	post	post	JJ
cord-275675-gzd75ks9	49	29	-	-	JJ
cord-275675-gzd75ks9	49	30	infection	infection	JJ
cord-275675-gzd75ks9	49	31	ANC	ANC	NNP
cord-275675-gzd75ks9	49	32	count	count	NN
cord-275675-gzd75ks9	49	33	.	.	.
cord-275675-gzd75ks9	50	1	Three	three	CD
cord-275675-gzd75ks9	50	2	patients	patient	NNS
cord-275675-gzd75ks9	50	3	died	die	VBD
cord-275675-gzd75ks9	50	4	in	in	IN
cord-275675-gzd75ks9	50	5	the	the	DT
cord-275675-gzd75ks9	50	6	week	week	NN
cord-275675-gzd75ks9	50	7	after	after	IN
cord-275675-gzd75ks9	50	8	testing	test	VBG
cord-275675-gzd75ks9	50	9	positive	positive	JJ
cord-275675-gzd75ks9	50	10	;	;	:
cord-275675-gzd75ks9	50	11	their	-PRON-	PRP$
cord-275675-gzd75ks9	50	12	data	datum	NNS
cord-275675-gzd75ks9	50	13	are	be	VBP
cord-275675-gzd75ks9	50	14	included	include	VBN
cord-275675-gzd75ks9	50	15	in	in	IN
cord-275675-gzd75ks9	50	16	the	the	DT
cord-275675-gzd75ks9	50	17	baseline	baseline	NN
cord-275675-gzd75ks9	50	18	and	and	CC
cord-275675-gzd75ks9	50	19	week	week	NN
cord-275675-gzd75ks9	50	20	1	1	CD
cord-275675-gzd75ks9	50	21	mean	mean	VBP
cord-275675-gzd75ks9	50	22	ANC	ANC	NNP
cord-275675-gzd75ks9	50	23	but	but	CC
cord-275675-gzd75ks9	50	24	missing	miss	VBG
cord-275675-gzd75ks9	50	25	for	for	IN
cord-275675-gzd75ks9	50	26	week	week	NN
cord-275675-gzd75ks9	50	27	2	2	CD
cord-275675-gzd75ks9	50	28	.	.	.
cord-275675-gzd75ks9	51	1	Two	two	CD
cord-275675-gzd75ks9	51	2	of	of	IN
cord-275675-gzd75ks9	51	3	the	the	DT
cord-275675-gzd75ks9	51	4	patients	patient	NNS
cord-275675-gzd75ks9	51	5	that	that	WDT
cord-275675-gzd75ks9	51	6	died	die	VBD
cord-275675-gzd75ks9	51	7	were	be	VBD
cord-275675-gzd75ks9	51	8	women	woman	NNS
cord-275675-gzd75ks9	51	9	,	,	,
cord-275675-gzd75ks9	51	10	two	two	CD
cord-275675-gzd75ks9	51	11	were	be	VBD
cord-275675-gzd75ks9	51	12	of	of	IN
cord-275675-gzd75ks9	51	13	non	non	JJ
cord-275675-gzd75ks9	51	14	-	-	JJ
cord-275675-gzd75ks9	51	15	White	white	JJ
cord-275675-gzd75ks9	51	16	heritage	heritage	NN
cord-275675-gzd75ks9	51	17	and	and	CC
cord-275675-gzd75ks9	51	18	one	one	CD
cord-275675-gzd75ks9	51	19	had	have	VBD
cord-275675-gzd75ks9	51	20	a	a	DT
cord-275675-gzd75ks9	51	21	BEN	BEN	NNP
cord-275675-gzd75ks9	51	22	diagnosis	diagnosis	NN
cord-275675-gzd75ks9	51	23	.	.	.
cord-275675-gzd75ks9	52	1	All	all	DT
cord-275675-gzd75ks9	52	2	had	have	VBD
cord-275675-gzd75ks9	52	3	been	be	VBN
cord-275675-gzd75ks9	52	4	on	on	IN
cord-275675-gzd75ks9	52	5	clozapine	clozapine	NN
cord-275675-gzd75ks9	52	6	for	for	IN
cord-275675-gzd75ks9	52	7	more	more	JJR
cord-275675-gzd75ks9	52	8	than	than	IN
cord-275675-gzd75ks9	52	9	a	a	DT
cord-275675-gzd75ks9	52	10	year	year	NN
cord-275675-gzd75ks9	52	11	.	.	.
cord-275675-gzd75ks9	53	1	The	the	DT
cord-275675-gzd75ks9	53	2	mean	mean	JJ
cord-275675-gzd75ks9	53	3	age	age	NN
cord-275675-gzd75ks9	53	4	at	at	IN
cord-275675-gzd75ks9	53	5	death	death	NN
cord-275675-gzd75ks9	53	6	was	be	VBD
cord-275675-gzd75ks9	53	7	65	65	CD
cord-275675-gzd75ks9	53	8	years	year	NNS
cord-275675-gzd75ks9	53	9	.	.	.
cord-275675-gzd75ks9	54	1	Medical	medical	JJ
cord-275675-gzd75ks9	54	2	comorbidities	comorbiditie	NNS
cord-275675-gzd75ks9	54	3	are	be	VBP
cord-275675-gzd75ks9	54	4	outlined	outline	VBN
cord-275675-gzd75ks9	54	5	in	in	IN
cord-275675-gzd75ks9	54	6	Table	Table	NNP
cord-275675-gzd75ks9	54	7	2	2	CD
cord-275675-gzd75ks9	54	8	.	.	.
cord-275675-gzd75ks9	55	1	The	the	DT
cord-275675-gzd75ks9	55	2	cause	cause	NN
cord-275675-gzd75ks9	55	3	of	of	IN
cord-275675-gzd75ks9	55	4	death	death	NN
cord-275675-gzd75ks9	55	5	was	be	VBD
cord-275675-gzd75ks9	55	6	given	give	VBN
cord-275675-gzd75ks9	55	7	as	as	IN
cord-275675-gzd75ks9	55	8	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	55	9	pneumonia	pneumonia	NN
cord-275675-gzd75ks9	55	10	in	in	IN
cord-275675-gzd75ks9	55	11	two	two	CD
cord-275675-gzd75ks9	55	12	cases	case	NNS
cord-275675-gzd75ks9	55	13	,	,	,
cord-275675-gzd75ks9	55	14	and	and	CC
cord-275675-gzd75ks9	55	15	myocardial	myocardial	JJ
cord-275675-gzd75ks9	55	16	infarction	infarction	NN
cord-275675-gzd75ks9	55	17	in	in	IN
cord-275675-gzd75ks9	55	18	the	the	DT
cord-275675-gzd75ks9	55	19	third	third	NN
cord-275675-gzd75ks9	55	20	.	.	.
cord-275675-gzd75ks9	56	1	There	there	EX
cord-275675-gzd75ks9	56	2	were	be	VBD
cord-275675-gzd75ks9	56	3	no	no	DT
cord-275675-gzd75ks9	56	4	statistically	statistically	RB
cord-275675-gzd75ks9	56	5	significant	significant	JJ
cord-275675-gzd75ks9	56	6	differences	difference	NNS
cord-275675-gzd75ks9	56	7	between	between	IN
cord-275675-gzd75ks9	56	8	mean	mean	JJ
cord-275675-gzd75ks9	56	9	ANC	ANC	NNP
cord-275675-gzd75ks9	56	10	at	at	IN
cord-275675-gzd75ks9	56	11	baseline	baseline	NN
cord-275675-gzd75ks9	56	12	and	and	CC
cord-275675-gzd75ks9	56	13	days	day	NNS
cord-275675-gzd75ks9	56	14	0	0	CD
cord-275675-gzd75ks9	56	15	-	-	SYM
cord-275675-gzd75ks9	56	16	7	7	CD
cord-275675-gzd75ks9	56	17	after	after	IN
cord-275675-gzd75ks9	56	18	the	the	DT
cord-275675-gzd75ks9	56	19	positive	positive	JJ
cord-275675-gzd75ks9	56	20	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	56	21	result	result	NN
cord-275675-gzd75ks9	56	22	(	(	-LRB-
cord-275675-gzd75ks9	56	23	p	p	NN
cord-275675-gzd75ks9	56	24	=	=	SYM
cord-275675-gzd75ks9	56	25	0.240	0.240	CD
cord-275675-gzd75ks9	56	26	)	)	-RRB-
cord-275675-gzd75ks9	56	27	,	,	,
cord-275675-gzd75ks9	56	28	between	between	IN
cord-275675-gzd75ks9	56	29	the	the	DT
cord-275675-gzd75ks9	56	30	mean	mean	JJ
cord-275675-gzd75ks9	56	31	ANC	ANC	NNP
cord-275675-gzd75ks9	56	32	on	on	IN
cord-275675-gzd75ks9	56	33	days	day	NNS
cord-275675-gzd75ks9	56	34	0	0	CD
cord-275675-gzd75ks9	56	35	-	-	SYM
cord-275675-gzd75ks9	56	36	7	7	CD
cord-275675-gzd75ks9	56	37	and	and	CC
cord-275675-gzd75ks9	56	38	days	day	NNS
cord-275675-gzd75ks9	56	39	8	8	CD
cord-275675-gzd75ks9	56	40	-	-	SYM
cord-275675-gzd75ks9	56	41	14	14	CD
cord-275675-gzd75ks9	56	42	(	(	-LRB-
cord-275675-gzd75ks9	56	43	p	p	NN
cord-275675-gzd75ks9	56	44	=	=	SYM
cord-275675-gzd75ks9	56	45	0.155	0.155	CD
cord-275675-gzd75ks9	56	46	)	)	-RRB-
cord-275675-gzd75ks9	56	47	,	,	,
cord-275675-gzd75ks9	56	48	or	or	CC
cord-275675-gzd75ks9	56	49	between	between	IN
cord-275675-gzd75ks9	56	50	baseline	baseline	JJ
cord-275675-gzd75ks9	56	51	ANC	ANC	NNP
cord-275675-gzd75ks9	56	52	and	and	CC
cord-275675-gzd75ks9	56	53	mean	mean	VB
cord-275675-gzd75ks9	56	54	ANC	ANC	NNP
cord-275675-gzd75ks9	56	55	on	on	IN
cord-275675-gzd75ks9	56	56	days	day	NNS
cord-275675-gzd75ks9	56	57	8	8	CD
cord-275675-gzd75ks9	56	58	-	-	SYM
cord-275675-gzd75ks9	56	59	14	14	CD
cord-275675-gzd75ks9	56	60	(	(	-LRB-
cord-275675-gzd75ks9	56	61	p	p	NN
cord-275675-gzd75ks9	56	62	=	=	SYM
cord-275675-gzd75ks9	56	63	0.509	0.509	CD
cord-275675-gzd75ks9	56	64	;	;	:
cord-275675-gzd75ks9	56	65	Figure	figure	NN
cord-275675-gzd75ks9	56	66	1	1	CD
cord-275675-gzd75ks9	56	67	)	)	-RRB-
cord-275675-gzd75ks9	56	68	.	.	.
cord-275675-gzd75ks9	57	1	This	this	DT
cord-275675-gzd75ks9	57	2	case	case	NN
cord-275675-gzd75ks9	57	3	series	series	NN
cord-275675-gzd75ks9	57	4	shows	show	VBZ
cord-275675-gzd75ks9	57	5	that	that	IN
cord-275675-gzd75ks9	57	6	no	no	DT
cord-275675-gzd75ks9	57	7	statistically	statistically	RB
cord-275675-gzd75ks9	57	8	significant	significant	JJ
cord-275675-gzd75ks9	57	9	change	change	NN
cord-275675-gzd75ks9	57	10	in	in	IN
cord-275675-gzd75ks9	57	11	ANC	ANC	NNP
cord-275675-gzd75ks9	57	12	occurred	occur	VBD
cord-275675-gzd75ks9	57	13	in	in	IN
cord-275675-gzd75ks9	57	14	patients	patient	NNS
cord-275675-gzd75ks9	57	15	taking	take	VBG
cord-275675-gzd75ks9	57	16	clozapine	clozapine	NN
cord-275675-gzd75ks9	57	17	who	who	WP
cord-275675-gzd75ks9	57	18	tested	test	VBD
cord-275675-gzd75ks9	57	19	positive	positive	JJ
cord-275675-gzd75ks9	57	20	for	for	IN
cord-275675-gzd75ks9	57	21	the	the	DT
cord-275675-gzd75ks9	57	22	novel	novel	JJ
cord-275675-gzd75ks9	57	23	coronavirus	coronavirus	NN
cord-275675-gzd75ks9	57	24	SARS	SARS	NNP
cord-275675-gzd75ks9	57	25	-	-	HYPH
cord-275675-gzd75ks9	57	26	CoV-2	CoV-2	NNP
cord-275675-gzd75ks9	57	27	.	.	.
cord-275675-gzd75ks9	58	1	We	-PRON-	PRP
cord-275675-gzd75ks9	58	2	observed	observe	VBD
cord-275675-gzd75ks9	58	3	no	no	DT
cord-275675-gzd75ks9	58	4	clear	clear	JJ
cord-275675-gzd75ks9	58	5	trend	trend	NN
cord-275675-gzd75ks9	58	6	for	for	IN
cord-275675-gzd75ks9	58	7	reduction	reduction	NN
cord-275675-gzd75ks9	58	8	in	in	IN
cord-275675-gzd75ks9	58	9	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	58	10	counts	count	NNS
cord-275675-gzd75ks9	58	11	during	during	IN
cord-275675-gzd75ks9	58	12	infection	infection	NN
cord-275675-gzd75ks9	58	13	.	.	.
cord-275675-gzd75ks9	59	1	There	there	EX
cord-275675-gzd75ks9	59	2	are	be	VBP
cord-275675-gzd75ks9	59	3	two	two	CD
cord-275675-gzd75ks9	59	4	major	major	JJ
cord-275675-gzd75ks9	59	5	clinical	clinical	JJ
cord-275675-gzd75ks9	59	6	implications	implication	NNS
cord-275675-gzd75ks9	59	7	.	.	.
cord-275675-gzd75ks9	60	1	First	first	RB
cord-275675-gzd75ks9	60	2	,	,	,
cord-275675-gzd75ks9	60	3	clozapine	clozapine	NN
cord-275675-gzd75ks9	60	4	should	should	MD
cord-275675-gzd75ks9	60	5	generally	generally	RB
cord-275675-gzd75ks9	60	6	be	be	VB
cord-275675-gzd75ks9	60	7	continued	continue	VBN
cord-275675-gzd75ks9	60	8	during	during	IN
cord-275675-gzd75ks9	60	9	coronavirus	coronavirus	NN
cord-275675-gzd75ks9	60	10	infection	infection	NN
cord-275675-gzd75ks9	60	11	.	.	.
cord-275675-gzd75ks9	61	1	Second	second	RB
cord-275675-gzd75ks9	61	2	,	,	,
cord-275675-gzd75ks9	61	3	patients	patient	NNS
cord-275675-gzd75ks9	61	4	taking	take	VBG
cord-275675-gzd75ks9	61	5	clozapine	clozapine	NN
cord-275675-gzd75ks9	61	6	who	who	WP
cord-275675-gzd75ks9	61	7	experience	experience	VBP
cord-275675-gzd75ks9	61	8	neutropaenia	neutropaenia	NNP
cord-275675-gzd75ks9	61	9	whilst	whilst	IN
cord-275675-gzd75ks9	61	10	suffering	suffer	VBG
cord-275675-gzd75ks9	61	11	from	from	IN
cord-275675-gzd75ks9	61	12	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	61	13	should	should	MD
cord-275675-gzd75ks9	61	14	be	be	VB
cord-275675-gzd75ks9	61	15	investigated	investigate	VBN
cord-275675-gzd75ks9	61	16	and	and	CC
cord-275675-gzd75ks9	61	17	monitored	monitor	VBN
cord-275675-gzd75ks9	61	18	as	as	IN
cord-275675-gzd75ks9	61	19	per	per	IN
cord-275675-gzd75ks9	61	20	normal	normal	JJ
cord-275675-gzd75ks9	61	21	practice	practice	NN
cord-275675-gzd75ks9	61	22	,	,	,
cord-275675-gzd75ks9	61	23	as	as	IN
cord-275675-gzd75ks9	61	24	it	-PRON-	PRP
cord-275675-gzd75ks9	61	25	can	can	MD
cord-275675-gzd75ks9	61	26	not	not	RB
cord-275675-gzd75ks9	61	27	be	be	VB
cord-275675-gzd75ks9	61	28	assumed	assume	VBN
cord-275675-gzd75ks9	61	29	to	to	TO
cord-275675-gzd75ks9	61	30	be	be	VB
cord-275675-gzd75ks9	61	31	secondary	secondary	JJ
cord-275675-gzd75ks9	61	32	to	to	IN
cord-275675-gzd75ks9	61	33	the	the	DT
cord-275675-gzd75ks9	61	34	viral	viral	JJ
cord-275675-gzd75ks9	61	35	infection	infection	NN
cord-275675-gzd75ks9	61	36	.	.	.
cord-275675-gzd75ks9	62	1	Viral	viral	JJ
cord-275675-gzd75ks9	62	2	infections	infection	NNS
cord-275675-gzd75ks9	62	3	,	,	,
cord-275675-gzd75ks9	62	4	including	include	VBG
cord-275675-gzd75ks9	62	5	influenza	influenza	NN
cord-275675-gzd75ks9	62	6	,	,	,
cord-275675-gzd75ks9	62	7	commonly	commonly	RB
cord-275675-gzd75ks9	62	8	cause	cause	VB
cord-275675-gzd75ks9	62	9	neutropaenia	neutropaenia	NNP
cord-275675-gzd75ks9	62	10	,	,	,
cord-275675-gzd75ks9	62	11	either	either	CC
cord-275675-gzd75ks9	62	12	by	by	IN
cord-275675-gzd75ks9	62	13	suppressing	suppress	VBG
cord-275675-gzd75ks9	62	14	bone	bone	NN
cord-275675-gzd75ks9	62	15	marrow	marrow	NN
cord-275675-gzd75ks9	62	16	production	production	NN
cord-275675-gzd75ks9	62	17	or	or	CC
cord-275675-gzd75ks9	62	18	accelerating	accelerate	VBG
cord-275675-gzd75ks9	62	19	peripheral	peripheral	JJ
cord-275675-gzd75ks9	62	20	destruction	destruction	NN
cord-275675-gzd75ks9	62	21	.	.	.
cord-275675-gzd75ks9	63	1	14	14	CD
cord-275675-gzd75ks9	63	2	Data	datum	NNS
cord-275675-gzd75ks9	63	3	from	from	IN
cord-275675-gzd75ks9	63	4	the	the	DT
cord-275675-gzd75ks9	63	5	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	63	6	outbreak	outbreak	NN
cord-275675-gzd75ks9	63	7	in	in	IN
cord-275675-gzd75ks9	63	8	China	China	NNP
cord-275675-gzd75ks9	63	9	suggest	suggest	VBP
cord-275675-gzd75ks9	63	10	that	that	IN
cord-275675-gzd75ks9	63	11	patients	patient	NNS
cord-275675-gzd75ks9	63	12	with	with	IN
cord-275675-gzd75ks9	63	13	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	63	14	infection	infection	NN
cord-275675-gzd75ks9	63	15	frequently	frequently	RB
cord-275675-gzd75ks9	63	16	present	present	JJ
cord-275675-gzd75ks9	63	17	with	with	IN
cord-275675-gzd75ks9	63	18	low	low	JJ
cord-275675-gzd75ks9	63	19	WCC	WCC	NNP
cord-275675-gzd75ks9	63	20	.	.	.
cord-275675-gzd75ks9	64	1	8	8	CD
cord-275675-gzd75ks9	64	2	,	,	,
cord-275675-gzd75ks9	64	3	11	11	CD
cord-275675-gzd75ks9	64	4	,	,	,
cord-275675-gzd75ks9	64	5	13	13	CD
cord-275675-gzd75ks9	65	1	This	this	DT
cord-275675-gzd75ks9	65	2	appears	appear	VBZ
cord-275675-gzd75ks9	65	3	to	to	TO
cord-275675-gzd75ks9	65	4	be	be	VB
cord-275675-gzd75ks9	65	5	due	due	JJ
cord-275675-gzd75ks9	65	6	to	to	IN
cord-275675-gzd75ks9	65	7	reduced	reduced	JJ
cord-275675-gzd75ks9	65	8	lymphocytes	lymphocyte	NNS
cord-275675-gzd75ks9	65	9	.	.	.
cord-275675-gzd75ks9	66	1	Lymphocytopenia	Lymphocytopenia	NNP
cord-275675-gzd75ks9	66	2	in	in	IN
cord-275675-gzd75ks9	66	3	patients	patient	NNS
cord-275675-gzd75ks9	66	4	with	with	IN
cord-275675-gzd75ks9	66	5	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	66	6	is	be	VBZ
cord-275675-gzd75ks9	66	7	shown	show	VBN
cord-275675-gzd75ks9	66	8	to	to	TO
cord-275675-gzd75ks9	66	9	be	be	VB
cord-275675-gzd75ks9	66	10	predictive	predictive	JJ
cord-275675-gzd75ks9	66	11	of	of	IN
cord-275675-gzd75ks9	66	12	disease	disease	NN
cord-275675-gzd75ks9	66	13	progression	progression	NN
cord-275675-gzd75ks9	66	14	,	,	,
cord-275675-gzd75ks9	66	15	correlating	correlate	VBG
cord-275675-gzd75ks9	66	16	with	with	IN
cord-275675-gzd75ks9	66	17	high	high	JJ
cord-275675-gzd75ks9	66	18	levels	level	NNS
cord-275675-gzd75ks9	66	19	of	of	IN
cord-275675-gzd75ks9	66	20	interleukins	interleukin	NNS
cord-275675-gzd75ks9	66	21	6	6	CD
cord-275675-gzd75ks9	66	22	and	and	CC
cord-275675-gzd75ks9	66	23	8	8	CD
cord-275675-gzd75ks9	66	24	and	and	CC
cord-275675-gzd75ks9	66	25	a	a	DT
cord-275675-gzd75ks9	66	26	severe	severe	JJ
cord-275675-gzd75ks9	66	27	or	or	CC
cord-275675-gzd75ks9	66	28	critical	critical	JJ
cord-275675-gzd75ks9	66	29	clinical	clinical	JJ
cord-275675-gzd75ks9	66	30	outcome	outcome	NN
cord-275675-gzd75ks9	66	31	.	.	.
cord-275675-gzd75ks9	67	1	15	15	CD
cord-275675-gzd75ks9	68	1	The	the	DT
cord-275675-gzd75ks9	68	2	increase	increase	NN
cord-275675-gzd75ks9	68	3	in	in	IN
cord-275675-gzd75ks9	68	4	inflammatory	inflammatory	JJ
cord-275675-gzd75ks9	68	5	cytokines	cytokine	NNS
cord-275675-gzd75ks9	68	6	causes	cause	VBZ
cord-275675-gzd75ks9	68	7	a	a	DT
cord-275675-gzd75ks9	68	8	rise	rise	NN
cord-275675-gzd75ks9	68	9	in	in	IN
cord-275675-gzd75ks9	68	10	neutrophils	neutrophil	NNS
cord-275675-gzd75ks9	68	11	as	as	IN
cord-275675-gzd75ks9	68	12	part	part	NN
cord-275675-gzd75ks9	68	13	of	of	IN
cord-275675-gzd75ks9	68	14	the	the	DT
cord-275675-gzd75ks9	68	15	initial	initial	JJ
cord-275675-gzd75ks9	68	16	antiviral	antiviral	JJ
cord-275675-gzd75ks9	68	17	immune	immune	JJ
cord-275675-gzd75ks9	68	18	response	response	NN
cord-275675-gzd75ks9	68	19	.	.	.
cord-275675-gzd75ks9	69	1	16	16	CD
cord-275675-gzd75ks9	70	1	The	the	DT
cord-275675-gzd75ks9	70	2	data	datum	NNS
cord-275675-gzd75ks9	70	3	we	-PRON-	PRP
cord-275675-gzd75ks9	70	4	present	present	VBP
cord-275675-gzd75ks9	70	5	here	here	RB
cord-275675-gzd75ks9	70	6	show	show	VBP
cord-275675-gzd75ks9	70	7	no	no	DT
cord-275675-gzd75ks9	70	8	significant	significant	JJ
cord-275675-gzd75ks9	70	9	change	change	NN
cord-275675-gzd75ks9	70	10	in	in	IN
cord-275675-gzd75ks9	70	11	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	70	12	counts	count	NNS
cord-275675-gzd75ks9	70	13	but	but	CC
cord-275675-gzd75ks9	70	14	faintly	faintly	RB
cord-275675-gzd75ks9	70	15	suggest	suggest	VBP
cord-275675-gzd75ks9	70	16	an	an	DT
cord-275675-gzd75ks9	70	17	initial	initial	JJ
cord-275675-gzd75ks9	70	18	small	small	JJ
cord-275675-gzd75ks9	70	19	fall	fall	NN
cord-275675-gzd75ks9	70	20	in	in	IN
cord-275675-gzd75ks9	70	21	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	70	22	counts	count	NNS
cord-275675-gzd75ks9	70	23	followed	follow	VBN
cord-275675-gzd75ks9	70	24	by	by	IN
cord-275675-gzd75ks9	70	25	a	a	DT
cord-275675-gzd75ks9	70	26	rise	rise	NN
cord-275675-gzd75ks9	70	27	,	,	,
cord-275675-gzd75ks9	70	28	in	in	IN
cord-275675-gzd75ks9	70	29	line	line	NN
cord-275675-gzd75ks9	70	30	with	with	IN
cord-275675-gzd75ks9	70	31	expected	expect	VBN
cord-275675-gzd75ks9	70	32	immune	immune	JJ
cord-275675-gzd75ks9	70	33	responses	response	NNS
cord-275675-gzd75ks9	70	34	to	to	IN
cord-275675-gzd75ks9	70	35	viral	viral	JJ
cord-275675-gzd75ks9	70	36	infection	infection	NN
cord-275675-gzd75ks9	70	37	.	.	.
cord-275675-gzd75ks9	71	1	Clozapine	Clozapine	NNP
cord-275675-gzd75ks9	71	2	-	-	HYPH
cord-275675-gzd75ks9	71	3	induced	induce	VBN
cord-275675-gzd75ks9	71	4	neutropaenia	neutropaenia	NNP
cord-275675-gzd75ks9	71	5	is	be	VBZ
cord-275675-gzd75ks9	71	6	an	an	DT
cord-275675-gzd75ks9	71	7	idiosyncratic	idiosyncratic	JJ
cord-275675-gzd75ks9	71	8	reaction	reaction	NN
cord-275675-gzd75ks9	71	9	,	,	,
cord-275675-gzd75ks9	71	10	possibly	possibly	RB
cord-275675-gzd75ks9	71	11	mediated	mediate	VBN
cord-275675-gzd75ks9	71	12	by	by	IN
cord-275675-gzd75ks9	71	13	direct	direct	JJ
cord-275675-gzd75ks9	71	14	binding	binding	NN
cord-275675-gzd75ks9	71	15	of	of	IN
cord-275675-gzd75ks9	71	16	metabolites	metabolite	NNS
cord-275675-gzd75ks9	71	17	to	to	IN
cord-275675-gzd75ks9	71	18	neutrophils	neutrophil	NNS
cord-275675-gzd75ks9	71	19	17	17	CD
cord-275675-gzd75ks9	71	20	and	and	CC
cord-275675-gzd75ks9	71	21	is	be	VBZ
cord-275675-gzd75ks9	71	22	rare	rare	JJ
cord-275675-gzd75ks9	71	23	beyond	beyond	IN
cord-275675-gzd75ks9	71	24	the	the	DT
cord-275675-gzd75ks9	71	25	first	first	JJ
cord-275675-gzd75ks9	71	26	3	3	CD
cord-275675-gzd75ks9	71	27	months	month	NNS
cord-275675-gzd75ks9	71	28	of	of	IN
cord-275675-gzd75ks9	71	29	treatment	treatment	NN
cord-275675-gzd75ks9	71	30	.	.	.
cord-275675-gzd75ks9	72	1	It	-PRON-	PRP
cord-275675-gzd75ks9	72	2	therefore	therefore	RB
cord-275675-gzd75ks9	72	3	seems	seem	VBZ
cord-275675-gzd75ks9	72	4	unlikely	unlikely	JJ
cord-275675-gzd75ks9	72	5	that	that	IN
cord-275675-gzd75ks9	72	6	taking	take	VBG
cord-275675-gzd75ks9	72	7	clozapine	clozapine	NN
cord-275675-gzd75ks9	72	8	would	would	MD
cord-275675-gzd75ks9	72	9	predispose	predispose	VB
cord-275675-gzd75ks9	72	10	patients	patient	NNS
cord-275675-gzd75ks9	72	11	to	to	IN
cord-275675-gzd75ks9	72	12	adverse	adverse	JJ
cord-275675-gzd75ks9	72	13	haematological	haematological	JJ
cord-275675-gzd75ks9	72	14	effects	effect	NNS
cord-275675-gzd75ks9	72	15	in	in	IN
cord-275675-gzd75ks9	72	16	viral	viral	JJ
cord-275675-gzd75ks9	72	17	infections	infection	NNS
cord-275675-gzd75ks9	72	18	,	,	,
cord-275675-gzd75ks9	72	19	since	since	IN
cord-275675-gzd75ks9	72	20	the	the	DT
cord-275675-gzd75ks9	72	21	immune	immune	JJ
cord-275675-gzd75ks9	72	22	response	response	NN
cord-275675-gzd75ks9	72	23	of	of	IN
cord-275675-gzd75ks9	72	24	neutrophils	neutrophil	NNS
cord-275675-gzd75ks9	72	25	to	to	IN
cord-275675-gzd75ks9	72	26	inflammatory	inflammatory	JJ
cord-275675-gzd75ks9	72	27	cytokines	cytokine	NNS
cord-275675-gzd75ks9	72	28	is	be	VBZ
cord-275675-gzd75ks9	72	29	not	not	RB
cord-275675-gzd75ks9	72	30	affected	affect	VBN
cord-275675-gzd75ks9	72	31	.	.	.
cord-275675-gzd75ks9	73	1	COVID-19	covid-19	JJ
cord-275675-gzd75ks9	73	2	infection	infection	NN
cord-275675-gzd75ks9	73	3	does	do	VBZ
cord-275675-gzd75ks9	73	4	not	not	RB
cord-275675-gzd75ks9	73	5	appear	appear	VB
cord-275675-gzd75ks9	73	6	to	to	TO
cord-275675-gzd75ks9	73	7	cause	cause	VB
cord-275675-gzd75ks9	73	8	a	a	DT
cord-275675-gzd75ks9	73	9	significant	significant	JJ
cord-275675-gzd75ks9	73	10	or	or	CC
cord-275675-gzd75ks9	73	11	prolonged	prolonged	JJ
cord-275675-gzd75ks9	73	12	neutropaenia	neutropaenia	NNS
cord-275675-gzd75ks9	73	13	in	in	IN
cord-275675-gzd75ks9	73	14	patients	patient	NNS
cord-275675-gzd75ks9	73	15	taking	take	VBG
cord-275675-gzd75ks9	73	16	clozapine	clozapine	NN
cord-275675-gzd75ks9	73	17	.	.	.
cord-275675-gzd75ks9	74	1	Patients	patient	NNS
cord-275675-gzd75ks9	74	2	should	should	MD
cord-275675-gzd75ks9	74	3	therefore	therefore	RB
cord-275675-gzd75ks9	74	4	continue	continue	VB
cord-275675-gzd75ks9	74	5	to	to	TO
cord-275675-gzd75ks9	74	6	receive	receive	VB
cord-275675-gzd75ks9	74	7	clozapine	clozapine	NN
cord-275675-gzd75ks9	74	8	and	and	CC
cord-275675-gzd75ks9	74	9	be	be	VB
cord-275675-gzd75ks9	74	10	assessed	assess	VBN
cord-275675-gzd75ks9	74	11	for	for	IN
cord-275675-gzd75ks9	74	12	the	the	DT
cord-275675-gzd75ks9	74	13	possibility	possibility	NN
cord-275675-gzd75ks9	74	14	of	of	IN
cord-275675-gzd75ks9	74	15	clozapine	clozapine	NN
cord-275675-gzd75ks9	74	16	-	-	HYPH
cord-275675-gzd75ks9	74	17	induced	induce	VBN
cord-275675-gzd75ks9	74	18	neutropaenic	neutropaenic	JJ
cord-275675-gzd75ks9	74	19	sepsis	sepsis	NN
cord-275675-gzd75ks9	74	20	if	if	IN
cord-275675-gzd75ks9	74	21	they	-PRON-	PRP
cord-275675-gzd75ks9	74	22	present	present	VBP
cord-275675-gzd75ks9	74	23	with	with	IN
cord-275675-gzd75ks9	74	24	fever	fever	NN
cord-275675-gzd75ks9	74	25	,	,	,
cord-275675-gzd75ks9	74	26	cough	cough	NN
cord-275675-gzd75ks9	74	27	,	,	,
cord-275675-gzd75ks9	74	28	myalgia	myalgia	NN
cord-275675-gzd75ks9	74	29	,	,	,
cord-275675-gzd75ks9	74	30	fatigue	fatigue	NN
cord-275675-gzd75ks9	74	31	or	or	CC
cord-275675-gzd75ks9	74	32	shortness	shortness	NN
cord-275675-gzd75ks9	74	33	of	of	IN
cord-275675-gzd75ks9	74	34	breath	breath	NN
cord-275675-gzd75ks9	74	35	,	,	,
cord-275675-gzd75ks9	74	36	18	18	CD
cord-275675-gzd75ks9	74	37	bearing	bear	VBG
cord-275675-gzd75ks9	74	38	in	in	IN
cord-275675-gzd75ks9	74	39	mind	mind	NN
cord-275675-gzd75ks9	74	40	that	that	IN
cord-275675-gzd75ks9	74	41	this	this	DT
cord-275675-gzd75ks9	74	42	is	be	VBZ
cord-275675-gzd75ks9	74	43	an	an	DT
cord-275675-gzd75ks9	74	44	extremely	extremely	RB
cord-275675-gzd75ks9	74	45	rare	rare	JJ
cord-275675-gzd75ks9	74	46	event	event	NN
cord-275675-gzd75ks9	74	47	in	in	IN
cord-275675-gzd75ks9	74	48	patients	patient	NNS
cord-275675-gzd75ks9	74	49	who	who	WP
cord-275675-gzd75ks9	74	50	have	have	VBP
cord-275675-gzd75ks9	74	51	been	be	VBN
cord-275675-gzd75ks9	74	52	established	establish	VBN
cord-275675-gzd75ks9	74	53	on	on	IN
cord-275675-gzd75ks9	74	54	treatment	treatment	NN
cord-275675-gzd75ks9	74	55	for	for	IN
cord-275675-gzd75ks9	74	56	more	more	JJR
cord-275675-gzd75ks9	74	57	than	than	IN
cord-275675-gzd75ks9	74	58	3	3	CD
cord-275675-gzd75ks9	74	59	months	month	NNS
cord-275675-gzd75ks9	74	60	.	.	.
cord-275675-gzd75ks9	75	1	The	the	DT
cord-275675-gzd75ks9	75	2	Maudsley	Maudsley	NNP
cord-275675-gzd75ks9	75	3	prescribing	prescribe	VBG
cord-275675-gzd75ks9	75	4	guidelines	guideline	NNS
cord-275675-gzd75ks9	75	5	in	in	IN
cord-275675-gzd75ks9	75	6	psychiatry	psychiatry	NN
cord-275675-gzd75ks9	76	1	The	the	DT
cord-275675-gzd75ks9	76	2	prevalence	prevalence	NN
cord-275675-gzd75ks9	76	3	of	of	IN
cord-275675-gzd75ks9	76	4	agranulocytosis	agranulocytosis	NN
cord-275675-gzd75ks9	76	5	and	and	CC
cord-275675-gzd75ks9	76	6	related	related	JJ
cord-275675-gzd75ks9	76	7	death	death	NN
cord-275675-gzd75ks9	76	8	in	in	IN
cord-275675-gzd75ks9	76	9	clozapinetreated	clozapinetreate	VBN
cord-275675-gzd75ks9	76	10	patients	patient	NNS
cord-275675-gzd75ks9	76	11	:	:	:
cord-275675-gzd75ks9	76	12	a	a	DT
cord-275675-gzd75ks9	76	13	comprehensive	comprehensive	JJ
cord-275675-gzd75ks9	76	14	meta	meta	JJ
cord-275675-gzd75ks9	76	15	-	-	HYPH
cord-275675-gzd75ks9	76	16	analysis	analysis	NN
cord-275675-gzd75ks9	76	17	of	of	IN
cord-275675-gzd75ks9	76	18	observational	observational	JJ
cord-275675-gzd75ks9	76	19	studies	study	NNS
cord-275675-gzd75ks9	76	20	International	International	NNP
cord-275675-gzd75ks9	76	21	trends	trend	NNS
cord-275675-gzd75ks9	76	22	in	in	IN
cord-275675-gzd75ks9	76	23	clozapine	clozapine	NN
cord-275675-gzd75ks9	76	24	use	use	NN
cord-275675-gzd75ks9	76	25	:	:	:
cord-275675-gzd75ks9	76	26	a	a	DT
cord-275675-gzd75ks9	76	27	study	study	NN
cord-275675-gzd75ks9	76	28	in	in	IN
cord-275675-gzd75ks9	76	29	17	17	CD
cord-275675-gzd75ks9	76	30	countries	country	NNS
cord-275675-gzd75ks9	76	31	Clozapine	Clozapine	NNP
cord-275675-gzd75ks9	76	32	-	-	HYPH
cord-275675-gzd75ks9	76	33	induced	induce	VBN
cord-275675-gzd75ks9	76	34	agranulocytosis	agranulocytosis	NN
cord-275675-gzd75ks9	76	35	-incidence	-incidence	NN
cord-275675-gzd75ks9	76	36	and	and	CC
cord-275675-gzd75ks9	76	37	risk	risk	NN
cord-275675-gzd75ks9	76	38	factors	factor	NNS
cord-275675-gzd75ks9	76	39	in	in	IN
cord-275675-gzd75ks9	76	40	the	the	DT
cord-275675-gzd75ks9	76	41	United	United	NNP
cord-275675-gzd75ks9	76	42	States	States	NNP
cord-275675-gzd75ks9	76	43	Risk	Risk	NNP
cord-275675-gzd75ks9	76	44	of	of	IN
cord-275675-gzd75ks9	76	45	clozapine	clozapine	NN
cord-275675-gzd75ks9	76	46	-	-	HYPH
cord-275675-gzd75ks9	76	47	associated	associate	VBN
cord-275675-gzd75ks9	76	48	agranulocytosis	agranulocytosis	NN
cord-275675-gzd75ks9	76	49	and	and	CC
cord-275675-gzd75ks9	76	50	mandatory	mandatory	JJ
cord-275675-gzd75ks9	76	51	white	white	JJ
cord-275675-gzd75ks9	76	52	blood	blood	NN
cord-275675-gzd75ks9	76	53	cell	cell	NN
cord-275675-gzd75ks9	76	54	monitoring	monitor	VBG
cord-275675-gzd75ks9	76	55	Optimizing	optimize	VBG
cord-275675-gzd75ks9	76	56	outcomes	outcome	NNS
cord-275675-gzd75ks9	76	57	in	in	IN
cord-275675-gzd75ks9	76	58	clozapine	clozapine	NNP
cord-275675-gzd75ks9	76	59	rechallenge	rechallenge	NN
cord-275675-gzd75ks9	76	60	following	follow	VBG
cord-275675-gzd75ks9	76	61	neutropenia	neutropenia	NN
cord-275675-gzd75ks9	76	62	:	:	:
cord-275675-gzd75ks9	77	1	a	a	DT
cord-275675-gzd75ks9	77	2	cohort	cohort	NN
cord-275675-gzd75ks9	77	3	analysis	analysis	NN
cord-275675-gzd75ks9	77	4	Figure	figure	NN
cord-275675-gzd75ks9	77	5	1	1	CD
cord-275675-gzd75ks9	77	6	.	.	.
cord-275675-gzd75ks9	78	1	Change	change	VB
cord-275675-gzd75ks9	78	2	in	in	IN
cord-275675-gzd75ks9	78	3	mean	mean	JJ
cord-275675-gzd75ks9	78	4	ANC	ANC	NNP
cord-275675-gzd75ks9	78	5	.	.	.
cord-275675-gzd75ks9	79	1	No	no	DT
cord-275675-gzd75ks9	79	2	statistically	statistically	RB
cord-275675-gzd75ks9	79	3	significant	significant	JJ
cord-275675-gzd75ks9	79	4	differences	difference	NNS
cord-275675-gzd75ks9	79	5	between	between	IN
cord-275675-gzd75ks9	79	6	mean	mean	JJ
cord-275675-gzd75ks9	79	7	ANC	ANC	NNP
cord-275675-gzd75ks9	79	8	at	at	IN
cord-275675-gzd75ks9	79	9	each	each	DT
cord-275675-gzd75ks9	79	10	time	time	NN
cord-275675-gzd75ks9	79	11	point	point	NN
cord-275675-gzd75ks9	79	12	ANC	ANC	NNP
cord-275675-gzd75ks9	79	13	,	,	,
cord-275675-gzd75ks9	79	14	absolute	absolute	JJ
cord-275675-gzd75ks9	79	15	neutrophil	neutrophil	NN
cord-275675-gzd75ks9	79	16	count	count	NN
cord-275675-gzd75ks9	79	17	Meta	Meta	NNP
cord-275675-gzd75ks9	79	18	-	-	HYPH
cord-275675-gzd75ks9	79	19	analysis	analysis	NN
cord-275675-gzd75ks9	79	20	examining	examine	VBG
cord-275675-gzd75ks9	79	21	the	the	DT
cord-275675-gzd75ks9	79	22	epidemiology	epidemiology	NN
cord-275675-gzd75ks9	79	23	of	of	IN
cord-275675-gzd75ks9	79	24	clozapineassociated	clozapineassociated	JJ
cord-275675-gzd75ks9	79	25	neutropenia	neutropenia	NNP
cord-275675-gzd75ks9	79	26	Clinical	clinical	JJ
cord-275675-gzd75ks9	79	27	features	feature	NNS
cord-275675-gzd75ks9	79	28	of	of	IN
cord-275675-gzd75ks9	79	29	patients	patient	NNS
cord-275675-gzd75ks9	79	30	infected	infect	VBN
cord-275675-gzd75ks9	79	31	with	with	IN
cord-275675-gzd75ks9	79	32	2019	2019	CD
cord-275675-gzd75ks9	79	33	novel	novel	JJ
cord-275675-gzd75ks9	79	34	coronavirus	coronavirus	NN
cord-275675-gzd75ks9	79	35	in	in	IN
cord-275675-gzd75ks9	79	36	Wuhan	Wuhan	NNP
cord-275675-gzd75ks9	79	37	,	,	,
cord-275675-gzd75ks9	79	38	China	China	NNP
cord-275675-gzd75ks9	79	39	Epidemiological	epidemiological	JJ
cord-275675-gzd75ks9	79	40	and	and	CC
cord-275675-gzd75ks9	79	41	clinical	clinical	JJ
cord-275675-gzd75ks9	79	42	characteristics	characteristic	NNS
cord-275675-gzd75ks9	79	43	of	of	IN
cord-275675-gzd75ks9	79	44	99	99	CD
cord-275675-gzd75ks9	79	45	cases	case	NNS
cord-275675-gzd75ks9	79	46	of	of	IN
cord-275675-gzd75ks9	79	47	2019	2019	CD
cord-275675-gzd75ks9	79	48	novel	novel	JJ
cord-275675-gzd75ks9	79	49	coronavirus	coronavirus	NN
cord-275675-gzd75ks9	79	50	pneumonia	pneumonia	NN
cord-275675-gzd75ks9	79	51	in	in	IN
cord-275675-gzd75ks9	79	52	Wuhan	Wuhan	NNP
cord-275675-gzd75ks9	79	53	,	,	,
cord-275675-gzd75ks9	79	54	China	China	NNP
cord-275675-gzd75ks9	79	55	:	:	:
cord-275675-gzd75ks9	80	1	a	a	DT
cord-275675-gzd75ks9	80	2	descriptive	descriptive	JJ
cord-275675-gzd75ks9	80	3	study	study	NN
cord-275675-gzd75ks9	80	4	Clinical	clinical	JJ
cord-275675-gzd75ks9	80	5	course	course	NN
cord-275675-gzd75ks9	80	6	and	and	CC
cord-275675-gzd75ks9	80	7	risk	risk	NN
cord-275675-gzd75ks9	80	8	factors	factor	NNS
cord-275675-gzd75ks9	80	9	for	for	IN
cord-275675-gzd75ks9	80	10	mortality	mortality	NN
cord-275675-gzd75ks9	80	11	of	of	IN
cord-275675-gzd75ks9	80	12	adult	adult	NN
cord-275675-gzd75ks9	80	13	inpatients	inpatient	NNS
cord-275675-gzd75ks9	80	14	with	with	IN
cord-275675-gzd75ks9	80	15	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	80	16	in	in	IN
cord-275675-gzd75ks9	80	17	Wuhan	Wuhan	NNP
cord-275675-gzd75ks9	80	18	,	,	,
cord-275675-gzd75ks9	80	19	China	China	NNP
cord-275675-gzd75ks9	80	20	:	:	:
cord-275675-gzd75ks9	81	1	a	a	DT
cord-275675-gzd75ks9	81	2	retrospective	retrospective	JJ
cord-275675-gzd75ks9	81	3	cohort	cohort	NN
cord-275675-gzd75ks9	81	4	study	study	NN
cord-275675-gzd75ks9	81	5	Clinical	clinical	JJ
cord-275675-gzd75ks9	81	6	characteristics	characteristic	NNS
cord-275675-gzd75ks9	81	7	of	of	IN
cord-275675-gzd75ks9	81	8	coronavirus	coronavirus	NN
cord-275675-gzd75ks9	81	9	disease	disease	NN
cord-275675-gzd75ks9	81	10	2019	2019	CD
cord-275675-gzd75ks9	81	11	in	in	IN
cord-275675-gzd75ks9	81	12	China	China	NNP
cord-275675-gzd75ks9	81	13	Clinical	clinical	JJ
cord-275675-gzd75ks9	81	14	characteristics	characteristic	NNS
cord-275675-gzd75ks9	81	15	of	of	IN
cord-275675-gzd75ks9	81	16	imported	import	VBN
cord-275675-gzd75ks9	81	17	cases	case	NNS
cord-275675-gzd75ks9	81	18	of	of	IN
cord-275675-gzd75ks9	81	19	COVID-19	covid-19	CD
cord-275675-gzd75ks9	81	20	in	in	IN
cord-275675-gzd75ks9	81	21	Jiangsu	Jiangsu	NNP
cord-275675-gzd75ks9	81	22	province	province	NN
cord-275675-gzd75ks9	81	23	:	:	:
cord-275675-gzd75ks9	81	24	a	a	DT
cord-275675-gzd75ks9	81	25	multicenter	multicenter	JJ
cord-275675-gzd75ks9	81	26	descriptive	descriptive	JJ
cord-275675-gzd75ks9	81	27	study	study	NN
cord-275675-gzd75ks9	81	28	.	.	.
cord-275675-gzd75ks9	82	1	Clin	Clin	NNP
cord-275675-gzd75ks9	82	2	Infect	Infect	NNP
cord-275675-gzd75ks9	82	3	Dis	Dis	NNP
cord-275675-gzd75ks9	82	4	.	.	.
cord-275675-gzd75ks9	82	5	Epub	Epub	NNP
cord-275675-gzd75ks9	82	6	ahead	ahead	RB
cord-275675-gzd75ks9	82	7	of	of	IN
cord-275675-gzd75ks9	82	8	print	print	NN
cord-275675-gzd75ks9	82	9	29	29	CD
cord-275675-gzd75ks9	82	10	Clinical	clinical	JJ
cord-275675-gzd75ks9	82	11	characteristics	characteristic	NNS
cord-275675-gzd75ks9	82	12	of	of	IN
cord-275675-gzd75ks9	82	13	138	138	CD
cord-275675-gzd75ks9	82	14	hospitalized	hospitalize	VBN
cord-275675-gzd75ks9	82	15	patients	patient	NNS
cord-275675-gzd75ks9	82	16	with	with	IN
cord-275675-gzd75ks9	82	17	2019	2019	CD
cord-275675-gzd75ks9	82	18	novel	novel	JJ
cord-275675-gzd75ks9	82	19	coronavirus	coronavirus	NN
cord-275675-gzd75ks9	82	20	-	-	HYPH
cord-275675-gzd75ks9	82	21	infected	infect	VBN
cord-275675-gzd75ks9	82	22	pneumonia	pneumonia	NN
cord-275675-gzd75ks9	82	23	in	in	IN
cord-275675-gzd75ks9	82	24	Wuhan	Wuhan	NNP
cord-275675-gzd75ks9	82	25	,	,	,
cord-275675-gzd75ks9	83	1	China	China	NNP
cord-275675-gzd75ks9	83	2	Severe	Severe	NNP
cord-275675-gzd75ks9	84	1	neutropenia	neutropenia	NN
cord-275675-gzd75ks9	84	2	:	:	:
cord-275675-gzd75ks9	85	1	a	a	DT
cord-275675-gzd75ks9	85	2	diagnostic	diagnostic	JJ
cord-275675-gzd75ks9	85	3	approach	approach	NN
cord-275675-gzd75ks9	85	4	Viral	viral	JJ
cord-275675-gzd75ks9	85	5	and	and	CC
cord-275675-gzd75ks9	85	6	host	host	NN
cord-275675-gzd75ks9	85	7	factors	factor	NNS
cord-275675-gzd75ks9	85	8	related	relate	VBN
cord-275675-gzd75ks9	85	9	to	to	IN
cord-275675-gzd75ks9	85	10	the	the	DT
cord-275675-gzd75ks9	85	11	clinical	clinical	JJ
cord-275675-gzd75ks9	85	12	outcome	outcome	NN
cord-275675-gzd75ks9	85	13	of	of	IN
cord-275675-gzd75ks9	85	14	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	85	15	.	.	.
cord-275675-gzd75ks9	86	1	Nature	nature	NN
cord-275675-gzd75ks9	86	2	.	.	.
cord-275675-gzd75ks9	87	1	Epub	Epub	NNP
cord-275675-gzd75ks9	87	2	ahead	ahead	RB
cord-275675-gzd75ks9	87	3	of	of	IN
cord-275675-gzd75ks9	87	4	print	print	NN
cord-275675-gzd75ks9	87	5	20	20	CD
cord-275675-gzd75ks9	87	6	Neutrophils	neutrophil	NNS
cord-275675-gzd75ks9	87	7	in	in	IN
cord-275675-gzd75ks9	87	8	viral	viral	JJ
cord-275675-gzd75ks9	87	9	infections	infection	NNS
cord-275675-gzd75ks9	87	10	:	:	:
cord-275675-gzd75ks9	87	11	current	current	JJ
cord-275675-gzd75ks9	87	12	concepts	concept	NNS
cord-275675-gzd75ks9	87	13	and	and	CC
cord-275675-gzd75ks9	87	14	caveats	caveat	NNS
cord-275675-gzd75ks9	87	15	Clozapine	Clozapine	NNP
cord-275675-gzd75ks9	87	16	,	,	,
cord-275675-gzd75ks9	87	17	agranulocytosis	agranulocytosis	NN
cord-275675-gzd75ks9	87	18	,	,	,
cord-275675-gzd75ks9	87	19	and	and	CC
cord-275675-gzd75ks9	87	20	benign	benign	JJ
cord-275675-gzd75ks9	87	21	ethnic	ethnic	JJ
cord-275675-gzd75ks9	87	22	neutropenia	neutropenia	NN
cord-275675-gzd75ks9	87	23	Management	Management	NNP
cord-275675-gzd75ks9	87	24	of	of	IN
cord-275675-gzd75ks9	87	25	clozapine	clozapine	NNP
cord-275675-gzd75ks9	87	26	treatment	treatment	NN
cord-275675-gzd75ks9	87	27	during	during	IN
cord-275675-gzd75ks9	87	28	the	the	DT
cord-275675-gzd75ks9	87	29	COVID-19	COVID-19	NNP
cord-275675-gzd75ks9	87	30	pandemic	pandemic	NN
cord-275675-gzd75ks9	88	1	The	the	DT
cord-275675-gzd75ks9	88	2	authors	author	NNS
cord-275675-gzd75ks9	88	3	would	would	MD
cord-275675-gzd75ks9	88	4	like	like	VB
cord-275675-gzd75ks9	88	5	to	to	TO
cord-275675-gzd75ks9	88	6	thank	thank	VB
cord-275675-gzd75ks9	88	7	the	the	DT
cord-275675-gzd75ks9	88	8	staff	staff	NN
cord-275675-gzd75ks9	88	9	in	in	IN
cord-275675-gzd75ks9	88	10	the	the	DT
cord-275675-gzd75ks9	88	11	pharmacy	pharmacy	NN
cord-275675-gzd75ks9	88	12	departments	department	NNS
cord-275675-gzd75ks9	88	13	at	at	IN
cord-275675-gzd75ks9	88	14	South	South	NNP
cord-275675-gzd75ks9	88	15	London	London	NNP
cord-275675-gzd75ks9	88	16	and	and	CC
cord-275675-gzd75ks9	88	17	the	the	DT
cord-275675-gzd75ks9	88	18	Maudsley	Maudsley	NNP
cord-275675-gzd75ks9	88	19	NHS	NHS	NNP
cord-275675-gzd75ks9	88	20	Foundation	Foundation	NNP
cord-275675-gzd75ks9	88	21	Trust	Trust	NNP
cord-275675-gzd75ks9	88	22	for	for	IN
cord-275675-gzd75ks9	88	23	their	-PRON-	PRP$
cord-275675-gzd75ks9	88	24	assistance	assistance	NN
cord-275675-gzd75ks9	88	25	in	in	IN
cord-275675-gzd75ks9	88	26	identifying	identify	VBG
cord-275675-gzd75ks9	88	27	patients	patient	NNS
cord-275675-gzd75ks9	88	28	for	for	IN
cord-275675-gzd75ks9	88	29	inclusion	inclusion	NN
cord-275675-gzd75ks9	88	30	in	in	IN
cord-275675-gzd75ks9	88	31	this	this	DT
cord-275675-gzd75ks9	88	32	study	study	NN
cord-275675-gzd75ks9	88	33	.	.	.
cord-275675-gzd75ks9	89	1	The	the	DT
cord-275675-gzd75ks9	89	2	authors	author	NNS
cord-275675-gzd75ks9	89	3	declare	declare	VBP
cord-275675-gzd75ks9	89	4	that	that	IN
cord-275675-gzd75ks9	89	5	there	there	EX
cord-275675-gzd75ks9	89	6	is	be	VBZ
cord-275675-gzd75ks9	89	7	no	no	DT
cord-275675-gzd75ks9	89	8	conflict	conflict	NN
cord-275675-gzd75ks9	89	9	of	of	IN
cord-275675-gzd75ks9	89	10	interest	interest	NN
cord-275675-gzd75ks9	89	11	.	.	.
cord-275675-gzd75ks9	90	1	The	the	DT
cord-275675-gzd75ks9	90	2	authors	author	NNS
cord-275675-gzd75ks9	90	3	received	receive	VBD
cord-275675-gzd75ks9	90	4	no	no	DT
cord-275675-gzd75ks9	90	5	financial	financial	JJ
cord-275675-gzd75ks9	90	6	support	support	NN
cord-275675-gzd75ks9	90	7	for	for	IN
cord-275675-gzd75ks9	90	8	the	the	DT
cord-275675-gzd75ks9	90	9	research	research	NN
cord-275675-gzd75ks9	90	10	,	,	,
cord-275675-gzd75ks9	90	11	authorship	authorship	NN
cord-275675-gzd75ks9	90	12	,	,	,
cord-275675-gzd75ks9	90	13	and/or	and/or	CC
cord-275675-gzd75ks9	90	14	publication	publication	NN
cord-275675-gzd75ks9	90	15	of	of	IN
cord-275675-gzd75ks9	90	16	this	this	DT
cord-275675-gzd75ks9	90	17	article	article	NN
cord-275675-gzd75ks9	90	18	.	.	.
cord-275675-gzd75ks9	91	1	Siobhan	Siobhan	NNP
cord-275675-gzd75ks9	91	2	Gee	Gee	NNP
cord-275675-gzd75ks9	91	3	https://orcid.org/0000-0003-1020-6777	https://orcid.org/0000-0003-1020-6777	VBP
cord-275675-gzd75ks9	91	4	David	David	NNP
cord-275675-gzd75ks9	91	5	Taylor	Taylor	NNP
cord-275675-gzd75ks9	91	6	https://orcid.org/0000-0002-2557-1710	https://orcid.org/0000-0002-2557-1710	VBZ